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Small RNAs and their associated RNA interference (RNAi) pathways underpin
diverse mechanisms of gene regulation and genome defense across all three king-
doms of life and are integral to virus–host interactions. In plants, fungi and many
animals, an ancestral RNAi pathway exists as a host defense mechanism whereby
viral double-stranded RNA is processed to small RNAs that enable recognition and
degradation of the virus. While this antiviral RNAi pathway is not generally
thought to be present in mammals, other RNAi mechanisms can influence infection
through both viral- and host-derived small RNAs. Furthermore, a burgeoning body
of data suggests that small RNAs in mammals can function in a non-cell autono-
mous manner to play various roles in cell-to-cell communication and disease
through their transport in extracellular vesicles. While vesicular small RNAs have
not been proposed as an antiviral defense pathway per se, there is increasing evi-
dence that the export of host- or viral-derived RNAs from infected cells can influ-
ence various aspects of the infection process. This review discusses the current
knowledge of extracellular RNA functions in viral infection and the technical chal-
lenges surrounding this field of research.
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1 | SMALL RNA-MEDIATED GENE REGULATION IN EUKARYOTES
Small RNA-mediated gene regulation is a central component of how eukaryotic organisms develop, adapt, and protect them-
selves from viruses and transposable elements. Small RNAs usually operate by guiding an Argonaute (AGO) protein to
another nucleic acid target through Watson–Crick base pair complementarity (Azlan, Dzaki, & Azzam, 2016). These interac-
tions lead to gene silencing, which can involve transcriptional, posttranscriptional or epigenetic mechanisms, depending on
the properties of the small RNA, AGO protein and target in a given organism (Munshi, Mohan, & Ahuja, 2016). In animals,
there are two prominent conserved RNA interference (RNAi) mechanisms: (a) the posttranscriptional regulation of gene
Received: 5 January 2019 Revised: 13 March 2019 Accepted: 14 March 2019
DOI: 10.1002/wrna.1535
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original
work is properly cited.
© 2019 The Authors. WIREs RNA published by Wiley Periodicals, Inc.
WIREs RNA. 2019;e1535. wires.wiley.com/rna 1 of 23
https://doi.org/10.1002/wrna.1535
expression by microRNAs (miRNAs) and (b) the posttranscriptional and transcriptional silencing of transposable elements by
the piwi-interacting RNA (piRNA) pathway (Bartel, 2018; Baulcombe, 2004; Hannon, 2002). Another important RNAi path-
way that is thought to be ancestral is “antiviral RNAi,” where viral dsRNA is processed into small interfering RNAs (siRNAs)
that bind the complementary sequences to degrade viral genomes (Ding & Voinnet, 2007). Antiviral RNAi is found in plants,
fungi and many animals, and can operate through non-cell autonomous mechanisms, spreading the signal from infected cells
to distant sites in the organism (Obbard, Gordon, Buck, & Jiggins, 2009). The concept of mobile small RNA, therefore, goes
hand-in-hand with antiviral RNAi in many organisms and in plants these discoveries date back two decades (Hamilton &
Baulcombe, 1999). Evidence suggests antiviral RNAi exists in pluripotent cells in mammals (Ding, Han, Wang, & Li, 2018)
but type I interferons (IFNs) are thought to be the main mechanism of antiviral defense in differentiated cells (Pare & Sullivan,
2014; tenOever, 2017).
Beyond the debated existence of antiviral RNAi in mammals, other RNAi pathways can influence the infection process
and these can involve both viral- or host-derived small RNA guides. Here we detail the functions of these diverse small RNAs
inside viral-infected cells. We then explore the recent literature suggesting that the transmission of small RNAs between cells
plays important functional roles in viral infections. We review the mechanisms for RNA transport between cells and highlight
the technical challenges for characterizing these pathways as well as new methodologies required to advance the field.
2 | VIRAL- AND HOST-DERIVED miRNAs INSIDE THE CELL: A DIVERSE
RANGE OF FUNCTIONS
miRNAs are the most extensively studied class of small RNA associated with viral–host interactions in mammals. The field of
miRNA research in animals evolved from characterization of their important roles in development and revolutionized our
understanding of posttranscriptional gene regulation (Alvarez-Garcia & Miska, 2005). Over the last decade it has become clear
that miRNAs are involved in regulating virtually every process in the cell and are important players in cancers and other dis-
eases (Mendell & Olson, 2012). miRNAs are a highly conserved class of endogenous small RNA that derive from hairpin
transcripts, generally produced by RNA polymerase II. The canonical biogenesis pathway involves processing of the primary
miRNA transcripts by the RNase III enzyme Drosha and cofactors (also called the microprocessor complex) in the nucleus.
The resulting precursor miRNA is then exported to the cytoplasm and further processed by another RNase III enzyme, Dicer,
resulting in a ~22 nucleotide (nt) double-stranded miRNA duplex which is loaded into the RNA-induced silencing complex
(RISC). The guide strand of the miRNA associates with an AGO protein in the RISC while the passenger strand is degraded
(Ha & Kim, 2014). The canonical mechanism of action of a miRNA is to bind to specific messenger RNAs (mRNAs) and
inhibit translation and/or accelerate de-adenylation (Bartel, 2018). Target recognition largely occurs via complementary base
pairing of the miRNA with the mRNA target (Lewis, Burge, & Bartel, 2005). Most evolutionarily conserved target sites are
found in the 30 untranslated (30UTR) of mRNAs and involve pairing with nucleotides 2–8 from the 50 end of the miRNA, ter-
med the “seed” (Brennecke, Stark, Russell, & Cohen, 2005; Lewis, Shih, Jones-Rhoades, Bartel, & Burge, 2003). In 2004, it
was shown that certain herpesviruses can hijack the host miRNA biogenesis machinery to express their own miRNAs (Pfeffer
et al., 2004). Subsequently, viral miRNAs have been identified in several other viral families, including Adenoviridae,
Flavirividae, Orthomyxoviridae, and Retroviridae (Fruci, Rota, & Gallo, 2017; Kincaid & Sullivan, 2012; Tycowski et al.,
2015). These studies have also revealed novel, noncanonical pathways for viral miRNA biogenesis which are independent of
Drosha (Xie & Steitz, 2014).
2.1 | Functional roles of viral miRNAs inside cells
Viral-encoded miRNAs can have diverse functions during infection through their regulation of viral or host genes, depicted in
Figure 1 (Kincaid & Sullivan, 2012; Tycowski et al., 2015). For example, an early report demonstrated that polyomaviruses
produce miRNAs which repress viral T antigen at late stages of infection as a mechanism of immune evasion (Sullivan,
Grundhoff, Tevethia, Pipas, & Ganem, 2005). In all of the diverse herpesvirus subfamilies, viral miRNAs have been shown to
target the viral immediate-early trans-activator proteins that drive viral replication. It is proposed that this regulation might be
key to maintaining latency while setting the appropriate threshold to respond to reactivation signals (Grey, 2015). At the same
time, viral miRNAs can also directly interact with host mRNAs to regulate cellular networks that promote persistence, replica-
tion, and/or immune evasion (Bruscella et al., 2017; Cullen, 2006). For example, the Epstein–Barr virus (EBV)-encoded
miRNA BART6 inhibits the induction of antiviral immune responses by targeting genes of the retinoic acid-inducible gene I
(RIG-I) signaling pathway (Lu et al., 2017), while miRNAs derived from the oncogenic human Kaposi's sarcoma-associated
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herpesvirus (KSHV) enhance the survival of infected cells by inhibiting genes involved in cell cycle and/or apoptosis
(Gottwein & Cullen, 2010; Liu, Happel, & Ziegelbauer, 2017).
2.2 | Enhancement of infection by direct interactions between cellular host miRNAs and viruses
Cellular host miRNAs can also impact viral infection through a range of diverse targets and in some cases this involves direct
interaction with viral genomes (Figure 1). For example, an early report showed that hepatitis C virus (HCV) has evolved a
binding site in its genome for miR-122, a miRNA naturally highly expressed in the liver (Jopling, Yi, Lancaster, Lemon, &
Sarnow, 2005). This interaction with miR-122 stabilizes the HCV genome and also leads to a derepression of miR-122 host
targets, which are associated with lipid metabolism (Sarnow & Sagan, 2016). Many other host miRNA binding sites have
since been reported in the genomes of diverse viral families (Trobaugh & Klimstra, 2017). In contrast to the miR-122-HCV
example, interaction with host miRNAs can also lead to a suppression of viral translation and replication. For example, the
myeloid expressed miRNA, miR-142-3p, binds to the 30 untranslated region of eastern equine encephalitis virus, suppressing
its replication in myeloid cells. This interaction appears to be advantageous to the virus, leading to reduced induction of the
host innate immune response (Trobaugh et al., 2014). Indeed, it is expected that rapidly evolving viruses would not maintain
genomic binding sites for host miRNAs if the interactions were not beneficial for the virus. Host miRNA–virus interactions,
therefore, are suggested as another viral mechanism to escape detection and clearance by the immune system and enable per-
sistent infections (Mahajan, Drake, & Chen, 2009).
Some viruses have also evolved to interact with specific host miRNAs in a way that leads to degradation of the miRNA
(McCaskill, Praihirunkit, Sharp, & Buck, 2015). For example, two different herpesviruses, murine cytomegalovirus and her-
pesvirus saimiri (HVS), have evolved distinct noncoding RNAs that interact with miR-27 and mediate its degradation
(Cazalla, Yario, Steitz, & Steitz, 2010; Libri et al., 2012; Marcinowski et al., 2012; Guo, Oei, & Steitz, 2015). It is assumed
that the function of this interaction is to block the natural regulatory mechanism of miR-27 (e.g., leading to an increase in the
host targets of miR-27). Indeed, it was further shown by the Steitz lab that miR-27 is a repressor of T cell activation and pro-
posed that the degradation of miR-27 by HVS enables constitutive activation of HVS-infected T cells, a key cell type for
latency (Guo, Riley, Iwasaki, & Steitz, 2014). Many additional host miRNA–virus interactions that lead to deregulation of the
host miRNAs and/or inhibit their functional capacity have since been reported, underscoring the idea that an individual
miRNA can be important enough for a virus to devote genome space to its inhibition.
2.3 | Cellular miRNA regulation and functions in defense
Cellular (host) miRNAs regulate nearly every signaling pathway inside the cells and they work in concert with transcription
factors to control initiation, maintenance, and resolution of cell response to injury and stress (Mendell & Olson, 2012). The
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FIGURE 1 Functions of microRNA (miRNA)–target interactions inside an infected cell. Viruses encode miRNAs which can regulate host
messenger RNAs (mRNAs), viral mRNAs, and host miRNAs to promote infection. At the same time infections lead to changes in host miRNA
expression which influences immune responses
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functions of host miRNAs inside infected cells have been reviewed in depth recently (Girardi, López, & Pfeffer, 2018;
Trobaugh & Klimstra, 2017), which we will not duplicate. We note, however, that it is not always trivial to understand
whether the up- or down-regulation of a given miRNA upon infection is driven by a viral or host mechanism. For example,
multiple viral infections, including enterovirus 71 (EV71) and dengue virus, lead to an up-regulation of miRNA-146
(Ho et al., 2014; S. Wu et al., 2013). This miRNA is part of a negative feedback loop to suppress the IFN response and miR-
146 targets the tumor necrosis factor (TNF) receptor associated factor 6 (Ho et al., 2014; S. Wu et al., 2013; Yoshida et al.,
2008). It is therefore possible that the upregulation of miR-146 upon infection is a natural host mechanism to control the
response, but this may also be modulated/enhanced by the virus. In order to interpret the pro- or anti-viral functions of
miRNAs that are dysregulated upon infection it is highly relevant to understand whether and how the infection also leads to
changes in the export of miRNAs, and their transmission to uninfected cells (explored further below).
At the same time, it is worth noting that some viral infections can lead to suppression of the entire miRNA pathway inside
of cells. As a viral mechanism, this would mean sacrificing the ability to exploit the miRNA pathway with viral miRNAs in
the infected cell, with the benefit that the antiviral properties of some host miRNAs would be inhibited. For example, the
poly(A) polymerase of mammalian poxviruses polyadenylates host miRNAs resulting in their degradation (Backes et al.,
2012), although this does not affect all miRNAs equally (Buck et al., 2015). Suppression of the host miRNA pathway upon
infection could also represent a host mechanism for boosting the IFN response, since certain miRNAs function as negative
regulators of the IFN pathway. In particular, the recognition of viral RNA results in the inhibition of miRNA biogenesis by
suppressing the activity of the microprocessor complex. This downregulation leads to the derepression of IFNB1 mRNA and
several IFN-stimulated genes (ISGs) (Witteveldt, Ivens, & Macias, 2018) which have been reported to be repressed by
miRNAs under normal conditions (Hsu et al., 2017; Witwer, Sisk, Gama, & Clements, 2010). Similarly, ISGs can be activated
by reducing the silencing activity of RISC through poly-ADP-ribosylation which also leads to derepression of miRNA targets
(Seo et al., 2013).
From the above examples it is clear that there are a multitude of possibilities for how cellular miRNA levels impact an
infected cell, and how individual miRNAs or the miRNA machinery can be modulated during infection (not all of which are
covered here). At the same time, emerging data suggest viral infections also impact the secretion of miRNAs from infected
cells, and this can include both viral- and host-derived miRNAs. In this review, we consider the extracellular realm when
thinking about the role of miRNAs and other small RNAs in viral infection.
3 | EXTRACELLULAR SMALL RNAS IN MAMMALS
It has long been known that various RNA species exist outside of cells in different body fluids, and can be released from cells
and internalized by other cells under physiological conditions (de Candia, De Rosa, Casiraghi, & Matarese, 2016; Hoy &
Buck, 2012; Valadi et al., 2007). Studies from the 1960s and 1970s showed that extracellular RNA is transferred between
fibroblast cells (Kolodny, 1971, 1972) and from macrophages to lymphocytes (Fishman, Hammerstrom, & Bond, 1963). The
transfer of RNA was also linked to induction of T cell-specific antigen in bone marrow lymphocytes (Archer, 1978). However,
the mechanisms and identity of RNA species were not examined. Another report suggested highly methylated RNA is released
from a diverse range of cells under physiological conditions, in a manner that is not associated with cell death (Stroun et al.,
1978). Despite these intriguing early findings, little was reported on extracellular RNA until 2008, when seminal papers
showed that miRNAs are present in body fluids outside of cells (X. Chen et al., 2008; Chim et al., 2008; Lawrie et al., 2008;
Mitchell et al., 2008). Furthermore, since the profile of miRNAs in biofluids was shown to change in pathological conditions,
this stimulated extensive commercial interest in their biomarker capacity (Fritz et al., 2016; Sohel, 2016). Around the same
time, in vitro studies showed that miRNAs and mRNAs are exported from cells in extracellular vesicles (EVs). These can
transfer the RNAs to other cells where they mediate changes in gene expression (Skog et al., 2008; Valadi et al., 2007). The
combination of these discoveries has led to an explosion of interest in the translational applications of EVs, and their miRNA
cargos, over the last 10 years. However, relatively little is known about the processes of RNA export and import and how this
is controlled in the cell. The majority of research in this area has focused on understanding EV composition and function.
4 | EXTRACELLULAR VESICLES—FORM AND FUNCTION
The term EVs refers to small organelles enclosed by a lipid bilayer membrane that are found outside cells. These vesicles can
be broadly divided into three subclasses based on their origins inside cells. Apoptotic bodies are released from cells
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undergoing apoptosis. Microvesicles (also microparticles or ectosomes) are 100–1,000 nm vesicles released by budding from
the plasma membrane, while exosomes are small vesicles (~100 nm) of endosomal origin which are released by fusion of mul-
tivesicular endosomes (MVEs) with the plasma membrane (Colombo, Raposo, & Théry, 2014; Yáñez-Mó et al., 2015). How-
ever, many studies have used the term exosomes without showing evidence for subcellular origin. Moreover, it has become
clear that widely used isolation methods (such as differential centrifugation) result in mixed EV populations (Konoshenko,
Lekchnov, Vlassov, & Laktionov, 2018; Lötvall et al., 2014) and EVs that are small (<100 nm) are not exclusively exosomes
(Kowal et al., 2016). For this reason, we will only use the term EVs in this review, even if the original paper refers to these as
exosomes. EVs have gained popularity in the last decade in part due to the fact that they can shuttle RNAs between cells and
also based on extensive literature showing their roles in many pathological contexts, including cancer (Becker et al., 2016; De
Toro, Herschlik, Waldner, & Mongini, 2015).
4.1 | Extracellular vesicles and the Trojan Horse hypothesis
There are many types of viral cargo that can be packaged in EVs for transport to other cells, including viruses themselves.
Indeed, it has long been hypothesized that viruses hijack cellular pathways of intercellular trafficking not only for biogenesis
of new viral particles but also as an important mode of infection. This “Trojan exosome hypothesis” proposed that viruses can
take advantage of cell-encoded vesicle trafficking systems to move between cells without the need of viral receptors for cell
entry and in order to evade detection by the immune system (Gould, Booth, & Hildreth, 2003). Many reports have demon-
strated that viruses can package full length viral genomes or mRNA in EVs, which are able to replicate and and/or contribute
to the establishment of infections in recipient cells (Bukong, Momen-Heravi, Kodys, Bala, & Szabo, 2014; Chivero et al.,
2014; Columba Cabezas & Federico, 2013; Cosset & Dreux, 2014; Dreux et al., 2012; Fu et al., 2017; Jaworski et al., 2014;
Mao et al., 2016; Mori et al., 2008; Ramakrishnaiah et al., 2013). The use of EVs for transmission of viral genomes or
mRNAs is reviewed further in van Dongen, Masoumi, Witwer, and Pegtel (2016) and may be particularly important for naked
virus transmission to occur without cell lysis (van der Grein, Defourny, Slot, & Nolte-'t Hoen, 2018). Here we focus on
describing the small RNAs that are exported from infected cells and the current thinking on their functions. We cover the
properties and functions of extracellular small RNAs that have been reported in a viral context, starting with a focus on
miRNAs and how their transfer in EVs to recipient cells might impact infection through canonical (gene silencing) or non-
canonical (Toll-like receptor [TLR] activation) mechanisms.
5 | DUAL ROLE OF miRNAs IN EVs: ACTIVATORS AND REPRESSORS OF
IMMUNE RESPONSES
In the last 5 years several reports have demonstrated that both host and viral miRNAs are transferred from infected cells to
other (noninfected) cells and this miRNA trafficking has been proposed to facilitate infection through the regulation of
immune responses (Kouwaki, Okamoto, Tsukamoto, Fukushima, & Oshiumi, 2017; Laganà et al., 2013). A detailed list of
findings from various studies is provided in Table 1 with several examples depicted in Figure 2. In the following section we
detail research on viral small RNAs released from cells infected with EBV and human immunodeficiency virus (HIV), where
there is the largest body of literature to date.
5.1 | Viral-derived small RNAs in EVs: Gene silencers and TLR activators
5.1.1 | Epstein–Barr virus
An early report from 2010 showed that EVs released from EBV-infected B cells contain viral miRNAs that are internalized by
recipient monocyte-derived dendritic cells (DCs). The authors showed proof-of-concept with reporter assays that EVs transfer
viral miRNAs from infected cells to other cells and demonstrated the immune-stimulatory gene CXCL11, a target of the viral
miRNA, was suppressed in recipient cells (Pegtel et al., 2010). A subsequent study by the same group showed that other clas-
ses of viral small RNAs from EBV-infected cells are also exported and can be transferred to recipient cells where they can
activate immune responses. Specifically, 50 polyphosphorylated EBV-encoded small RNA (EBER1) is transferred via EVs to
naive DCs which drive of antiviral immunity (Baglio et al., 2016). It is expected that the transfer of 50 polyphosphorylated
RNAs in EVs might be a broad mechanism for “warning” cells of stress and infection. For example, transfer of naked (not
bound to protein) 7S RNA (which contains a 50 triphosphate) in EVs from stromal cells activates RIG-I in recipient cancer
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cells, linking inflammation and cancer progression (Nabet et al., 2017). In EBV infection, immune stimulation by EV-
imported RNA is thought to aid containment of the virus during the primary infection but can lead to chronic inflammation
during latency (Baglio et al., 2016). These examples suggest multiple classes of viral-derived small RNA can influence
noninfected host cells, through canonical and noncanonical mechanisms. Further work is required to understand whether the
release of particular viral RNAs is specific to certain cell types and stages of infection (lytic vs. latent) and the extent to which
these can signal to near or distant cell types in vivo.
5.1.2 | Human immunodeficiency virus
Small RNAs derived from the HIV genome have been reported both in intra- and extra-cellular contexts (Barclay et al., 2017;
Bernard et al., 2014; Harwig, Jongejan, van Kampen, Berkhout, & Das, 2016; Klase et al., 2007, 2009; Narayanan et al.,
2013; Narayanan, Kehn-Hall, Bailey, & Kashanchi, 2011; Ouellet et al., 2008; Sampey et al., 2016; Schopman et al., 2012;
Yeung et al., 2009). In particular, multiple studies showed that HIV-1 trans-activation response element RNA (TAR) can be
TABLE 1 Virus- or host-derived extracellular small RNAs and their proposed functions during infection
Viral infection Viral small RNA Target/function
Viral
replication References
EBV BART, BHRF1-3 BHRF1-3: Downregulation of cxcl11 gene in DCs
BART: Interaction with LMP1 (viral protein)
"? Pegtel et al. (2010)
50pppEBER1 Activation of DCs ? Baglio et al. (2016)
HIV-1 TAR miRNAs Induction of NF-κB pathway, facilitate viral
infection of uninfected cells
" Narayanan et al. (2013);
Sampey et al. (2016)
vmiR-88, vmiR99 Release of TNFα through activation of TLR8 signaling ? Bernard et al. (2014)
KSHV miR-K12-10a-3p,
K12-4-3p, K12-8-3p
Induction of aerobic glycolysis, reduced
mitochondria biogenesis
"? Yogev et al. (2017)
Viral
infection Host miRNA Target/function
Viral
replication References
HCV miR-19a Inhibition of SOC3, role in fibrosis ? Devhare et al. (2017)
miR-29 "? # Zhou et al. (2016)
miR-122 Viral genome stabilization " Ramakrishnaiah et al. (2013);
Bukong et al. (2014)
HBV miR-29, miR-21 Inhibition of IL-12 in macrophages " Kouwaki et al. (2016)
miR-122 Viral genome stabilization? Role in
replication?
" Novellino et al. (2012); W. Wang,
Li, Zhang, et al., 2016
IAV miR-483 Activation of RIG-I pathway # Maemura et al. (2018)
miR-17 Inhibition of antiviral factor Mx1 " Scheller et al. (2018)
PV, VV,
HSV-1
C19MC cluster Induction of autophagy # Delorme-Axford et al. (2013)
hCMV C19MC cluster ? " Delorme-Axford et al. (2013)
EV71 miR-146a Inhibition of IFN immune response " Fu et al. (2017)
REV +
ALV-J
miR-184, miR-146, miR-155
(all "), miR-3538 (#)
? "? Zhou et al. (2018)
JEV let-7a/b Neuronal damage and release of
proinflammatory cytokines
? Mukherjee et al. (2018)
HIV-1 Multiple miRNAs Inhibition of immune response due to
export of miRNA
" Aqil et al. (2014)
Note. #, inhibited; ", enhanced; ?, unknown.
Abbreviation: 50pppEBER1, 50 polyphosphorylated EBV-encoded small RNA; ALV-J, avian leukosis virus subgroup J; C19MC, chromosome 19 miRNA cluster; DC,
dendritic cells; EBV, Epstein–Barr virus; EV71, enterovirus 71; HBV, hepatitis B virus; hCMV, XXX; HCV, Hepatitis C virus; HIV-1, human immunodeficiency virus
1; HSV-1, herpes simplex virus 1; IAV, Influenza A virus; IFN, interferon; JEV, Japanese Encephalitis virus; KSHV, Kaposi's sarcoma-associated herpesvirus; PV,
poliovirus; REV, reticuloendotheliosis virus; RIG-I, retinoic acid-inducible gene I; TNFα, tumor necrosis factor α; VV, vaccinia virus.
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processed into two miRNA-like molecules, 50 TAR and 30 TAR (Klase et al., 2007, 2009; Narayanan et al., 2011; Ouellet
et al., 2008). Both 50 and 30 TAR, together with the longer TAR RNA have been found in EVs isolated from culture superna-
tant of infected cells and patient sera (Narayanan et al., 2013). The transfer of TAR RNAs from infected to uninfected cells
via EVs leads to the inhibition of pro-apoptotic transcripts, thus preventing programmed cell death in the recipient cells and
leaving them susceptible to HIV-1 infection (Narayanan et al., 2013). Although the authors could not establish the exact mech-
anism of action or the actual involvement of the TAR RNAs, the fact that HIV-derived RNAs have been detected in patient
serum is intriguing, as it indicates release and potential functions in vivo.
Additionally, 50 and 30 TAR contained in EVs have been proposed to interact with TLRs 7 and 8 in recipient cells, to acti-
vate NF-κB and regulate cytokine production during latency (Sampey et al., 2016). The authors showed interaction of
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FIGURE 2 Functional modes of secreted (viral) microRNAs (miRNAs). Host- and viral-encoded miRNAs which are transcribed in the
nucleus and processed in the nucleus and cytoplasm can be exported from the cell in extracellular vesicles (EVs). Export pathways involve
multivesicular endosomes (MVEs) or budding from the plasma membrane. Viral miRNAs when transferred to recipient cells can promote/inhibit
infection by regulating gene transcripts. Examples are shown involving viral miRNA transfer to dendritic cells (DCs) or macrophages (MΦ) that can
lead to chronic inflammation through the activation of toll-like receptors (TLRs). Host miRNAs transmitted from infected to uninfected cells can
either enhance or suppress viral infections and/or contribute to chronic inflammation. Antiviral immune responses can be suppressed by host
miRNAs that target the interferon (IFN) pathway in epithelial cells (Epi) or through inhibition of macrophage activation. On the other hand, host
miRNAs can activate the IFN response by suppressing negative regulators of the retinoic acid-inducible gene I (RIG-I). Other mechanisms of host
defense include the activation of autophagy
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synthetic TAR small RNAs and TLRs using pull down assays, however, we note that it is not currently known how RNAs
entering the cell naturally through EVs access the endosomal TLRs. Another study showed that HIV-encoded miRNAs
derived from the viral long terminal repeat region, vmiR88 and vmiR99 are transferred in EVs and stimulate TNFα release
from recipient macrophages through TLR8 signaling (Barclay et al., 2017; Bernard et al., 2014; Sampey et al., 2016). These
RNA-induced functions are proposed to contribute to the chronic immune activation seen in HIV-1 infected patients (Barclay
et al., 2017; Bernard et al., 2014; Sampey et al., 2016).
It has also been reported in other contexts including cancer studies that small RNAs contained in EVs can interact with
TLRs (Driedonks & Nolte-'t Hoen, 2018; Fabbri, Paone, Calore, Galli, & Croce, 2013; van der Grein & Nolte-'t Hoen, 2014).
Further work is required to understand how RNAs access TLRs in the endosomal system, for example, whether the RNA is
transported across the EV membrane within the endosome, whether the EV is destroyed within the endosome or whether the
EV-RNA is released in the cytoplasm but can subsequently reach the endosome. In general, very little is known about the fate
of an EV inside the target recipient cell, and research in this area could advance understanding in multiple biological and dis-
ease areas.
5.2 | Secreted host miRNAs activate immune responses and counteract viral infections
Viral infections not only lead to release of viral small RNAs in EVs but can also alter the extracellular profile of host miRNAs.
The functions of extracellular host miRNAs appear to be diverse: they have been proposed to benefit the host by antagonizing
viral spreading and replication and in other cases benefit the virus by suppressing antiviral immune responses and facilitating
infection (Table 1 and Figure 2).
Several studies have shown that cells infected by viruses release higher levels of specific host miRNAs in EVs. For exam-
ple, the EVs from HCV-infected macrophages contain miR-29 family members which inhibit viral replication in recipient
hepatocytes (Y. Zhou et al., 2016). Elevated levels of miR-29 were also found in EVs isolated from hepatitis B virus (HBV)-
infected hepatocytes (compared to EVs from uninfected hepatocytes). In this case, miR-29 together with miR-21 was trans-
ferred from hepatocytes to recipient macrophages. The transfer of both miRNAs resulted in suppression of the innate immune
response by inhibiting IL-12 expression, a cytokine known to activate natural killer cells (Kouwaki et al., 2016). These two
examples demonstrate how the same extracellular miRNA, miR-29, might have different functions (antiviral vs. proviral) in
different contexts. Understanding the natural recipient/target cell of the EVs is imperative to understanding the function of the
EV RNA cargo.
Another interesting example showing the functional relevance of extracellular miRNAs comes from the chromosome
19 miRNA cluster (C19MC), which is found in EVs derived from human placental trophoblasts (Delorme-Axford et al.,
2013). This miRNA cluster is almost exclusively expressed in the placenta (Bentwich et al., 2005) and represents the most
abundant miRNAs in trophoblastic EVs (Donker et al., 2012). When transferred to nonplacental cells these miRNAs induce
upregulation of pro-autophagy transcripts which inhibit viral replication of several viruses (Figure 2), including poliovirus,
vaccinia virus, and herpes simplex virus 1 (Delorme-Axford et al., 2013). However, a different study suggests that the antiviral
effect of the EVs might be at least partly mediated by the unique protein and phospholipid composition (Ouyang et al., 2016).
These examples illustrate a challenge in the EV field: how to delineate the importance and function of the RNA from the rest
of the EV cargo (Box 1).
5.3 | Secreted host miRNAs promote viral infection and contribute to pathology
Several studies have demonstrated that host miRNAs secreted in EVs can also promote infection (Table 1), and it is tempting
to speculate that viruses might have evolved mechanisms to modulate the sorting of extracellular miRNAs. EVs derived from
EV71-infected cells, for example, were preferentially enriched for miR-146a, the miRNA that has been well-documented to
inhibit type I IFN responses (as described above). It was shown that the transfer of this miRNA in EVs resulted in suppression
of type I IFN responses in recipient cells (Fu et al., 2017). In this report, the EVs were also found to contain the RISC proteins
Argonaute 2 (AGO2) and GW182 and the authors suggest the transfer of the miRNA-RISC complex might enable suppression
of targets immediately after cell entry. miR-146a was also reported to be strongly increased in EVs isolated from cells coin-
fected with reticuloendotheliosis virus and avian leukosis virus subgroup J. Although a function of the secreted miRNAs was
not explicitly shown in this report, bioinformatic target prediction suggests participation in virus–vector integration and energy
metabolism (D. Zhou et al., 2018). Since miR-146 is known to be upregulated inside infected cells, it will be of interest to
understand if the increased secretion of miR-146 involves passive or active sorting mechanisms (Box 1).
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Another report demonstrates increased levels of several miRNAs, including miR-17-5p, in EVs isolated from lung epithe-
lial cells and bronchoalveolar lavage fluid of Influenza A virus (IAV)-infected patients. Transfer of this miRNA to primary
alveolar cells leads to the downregulation of the antiviral factor MX1, thereby potentiating IAV infection (Scheller et al.,
2018). EV-miRNAs also contribute to the pathogenesis of the Japanese Encephalitis virus infection, in this case let-7a/b secre-
tion is increased upon infection of microglia cells and these miRNAs are transferred to neurons, causing damage and inflam-
mation (Mukherjee et al., 2018). Infection can also lead to an increase in secretion of miRNAs that are thought to be antiviral.
In theory, this could involve viral mechanisms aimed at reducing miRNA levels inside the infected cell, or host mechanisms
to transfer antiviral signaling to uninfected cells. For example, there is some evidence that HIV-1 protein Nef mediates the
selective export of miRNAs which have been predicted to target the viral genome or activate antiviral immune responses
(Aqil et al., 2014). Given the diversity of miRNA functions inside of infected cells, it is expected that many more examples
will emerge for their functions in transmitting information to uninfected cells, which may also fill-in some gaps in knowledge
of viral-induced pathologies.
5.4 | Impact of extracellular RNAs on virus-induced pathologies: Cancer and fibrosis
Emerging data suggest EVs and miRNAs contribute to viral-induced malignant transformation of cells infected with KSHV, a
gamma herpesvirus associated with abnormal endothelial proliferation and oncogenesis. During latent infection, only a small
BOX 1
THE BIG QUESTIONS AND CHALLENGES IN EXTRACELLULAR RNA RESEARCH
Separating RNA signals from waste
Do the same cells release RNA both as a signaling mechanism and a clearance mechanism? Do these involve dif-
ferent ribonucleoprotein complexes of EV subsets?
• Technological developments are required to separate different extracellular RNA-containing complexes, including different EV subsets.
• Careful consideration is required to prevent contaminants, for example, from calf serum used in cell culture experiments.
Linking intracellular and extracellular RNA regulation
Does the up- or down-regulation of RNAs upon infection inside the cell influence extracellular RNA levels? Do
passive or active sorting mechanisms dictate what is released? Have viruses evolved to control these processes?
• Basic research is required to identify the factors required for RNA sorting/export and genetic and synthetic strategies are needed to block these processes
for functional interrogation.
Concentration and localization of imported RNA
Is the amount of RNA imported into a cell is sufficient to raise its concentration to a functional level, in particular
for RNAs involved in gene silencing?
• Quantitative data on imported RNA levels under physiological conditions are required, along with new methods to track imported RNAs, including
studies of cross-species RNA transfer.
• Further understanding on the subcellular localization of imported RNA is required to understand the relationship between its concentration and activity.
Vesicular RNA: When the whole is greater than the sum of the parts
Is RNA the only functional cargo of a given EV population? Does RNA work in concert with the other signaling
molecules? How do we interrogate the contribution of the RNA cargo?
• Further characterization of the complexes in EVs (ribonucleoprotein complexes) will enable more sophisticated reductionist approaches to study
extracellular RNA.
• Strategies to block imported RNA in recipient cells (e.g. synthetic inhibitors) will help distinguish the functions of RNAs from other EV cargos.
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subset of genes, including 12 viral miRNAs, are expressed. A recent study showed these viral miRNAs are transmitted in EVs
from infected to adjacent, healthy cells, where they induce a metabolic shift toward aerobic glycolysis. The viral miRNAs act
on targets that reduce mitochondrial respiration in the recipient cells. This shift to aerobic glycolysis is characteristic of cancer
cells and establishes a novel mechanism by which viral miRNAs can manipulate the tumor microenvironment (Yogev
et al., 2017).
The transmission of cellular miRNAs from virus-infected cells has also been associated with liver fibrosis. Chronic HCV
infection is associated with high risk of liver fibrosis and primary hepatocellular carcinoma (Affo, Yu, & Schwabe, 2017).
Hepatic stellate cells are liver-specific mesenchymal cells regarded as major players in tumor initiation and development and
are a major source of extracellular proteins during fibrogenesis (Thompson, Conroy, & Henderson, 2015; Yin, Evason,
Asahina, & Stainier, 2013). While HCV cannot infect stellate cells, Devhare et al. showed that virally infected hepatocytes
secret EVs that contain miRNAs capable of activating genes related to liver fibrosis in the stellate cells, by targeting and
suppressing their inhibitors. Among the secreted miRNAs is miR-19a, a fibrosis enhancer that targets SOC3, a powerful nega-
tive regulator of STAT3 signaling associated with liver inflammation, fibrosis and carcinogenesis (G. He & Karin, 2011;
Devhare et al., 2017). Together, these examples demonstrate the impact that extracellular miRNAs from infected cells can
have on the microenvironment and how these molecules can shape not only the outcome of the viral infection but also associ-
ated pathologies.
6 | OTHER FUNCTIONS OF EXTRACELLULAR RNA IN VIRAL INFECTIONS
6.1 | Transmission of HCV in EVs—A role for miR-122?
In the liver miRNome, miR-122 accounts for more than 50% of total miRNA. This miRNA is involved in normal liver devel-
opment and homeostasis and is an essential host-factor required for efficient HCV replication (Shimakami et al., 2012). A
recent study showed that HCV-infected hepatocytes release EVs that contain complexes of viral RNA, AGO2 and miR-122
both in vivo and in hepatoma cell lines (Bukong et al., 2014). It has been shown that EVs collected from HCV-infected cells
can initiate in vitro a productive infection (Figure 3), even when treated with antibodies isolated from chronic HCV patients
(Bukong et al., 2014; Ramakrishnaiah et al., 2013). However, other reports found that EVs derived from infected cells carry
on their surface viral glycoproteins able to trigger immune responses (Masciopinto et al., 2004). These examples highlight one
issue in the EV field: there may be multiple EV subsets that derive from an individual cell, that behave differently (Box 1).
Host pre-miRNAs
Viral RNA
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FIGURE 3 Proposed mechanism for transmission of hepatitis C virus (HCV) in extracellular vesicles (EVs) in complex with miR-122. HCV
genomic RNA is exported from infected cells in EVs in a complex with miR-122 and Argonaute 2 (AGO2) protein. The absence of viral surface
protein prevents immune recognition and allows the transfer to uninfected cells where the virus replicates. EVs harboring viral proteins on their
surface are recognized by the immune system and fail to establish viral infection in uninfected cells
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One report by Dreux et al. (2012) showed that the HCV RNA cargo of EVs from infected cells activates plasmacytoid den-
dritic cells, which could be a host strategy to elicit an innate immune response in nonpermissive cells. Alternatively, the export
of HCV RNA could be a viral strategy to evade detection of the RNA in the infected cell. As with many viral–host interac-
tions, it is not trivial to understand who is calling the shots and further understanding of how RNA export is controlled may
shed light on these issues.
What is the importance of the miR-122-HCV interaction in EVs—Does this play any role in localization, export and trans-
mission of the virus, beyond stabilization of the viral genome? Further work is required to understand the mechanisms
involved here and this example underscores the concept that we should not limit our thinking on the function of miRNAs in
viral infection to just the infected cell, or to canonical miRNA functions in gene silencing.
6.2 | HBV extracellular particles—A secret shuttle for RNA?
During its replicative cycle, HBV is known to produce excess hepatitis B surface proteins (HBs) (Heermann et al., 1984), viral
proteins that can self-assemble into empty, subviral particles that lack a genome (Berkower et al., 2011) but can bind to cell
surface receptors (Chai et al., 2008). A recent study showed that HBs particles isolated from peripheral blood of HBV-infected
individuals contain miRNAs and AGO2. In particular, the HBs particles carry liver-specific miRNAs, such as miR-122, as
well as immune regulatory miRNAs including miR-223 and miR-106b. The authors suggest that most of these miRNA target
genes associated with viral transmission, including clathrin-mediated endocytosis and virus entry. This raises the question of
whether HBs particles play a role in viral spread and pathogenesis through their miRNA cargo and how miRNA incorporation
into HBs particles is dictated. This study found HBs-associated miRNAs to be different from EV-miRNAs released from
infected cells, which could indicate distinct mechanisms of miRNA sorting and secretion (Novellino et al., 2012). These
results were confirmed by another study that was able to isolate miRNAs from extracellular HBs particles (W. Wang
et al., 2016).
7 | LOOKING BEYOND miRNAs—RIBOSOMAL RNA AND TRANSFER RNA
FRAGMENTS IN EXTRA-CELLULAR ENVIRONMENTS
The majority of literature on extracellular RNAs focuses on miRNAs and this bias is most likely due to the fact that miRNAs
are relatively easy to identify and there is a model for how they function. However, there is a mounting consensus in the litera-
ture suggesting miRNAs are not the most abundant RNA species in EVs. Rather, fragments of other noncoding RNAs includ-
ing ribosomal RNA (rRNA), transfer RNA (tRNA) YRNAs, 7S RNA, and Vault RNAs are generally more abundant in EVs
than individual miRNAs and their levels in EVs are enriched compared to intracellularly (Chahar, Corsello, Kudlicki,
Komaravelli, & Casola, 2018; Driedonks et al., 2018; Lässer et al., 2017; Nolte-'t Hoen et al., 2012; Pérez-Boza, Lion, &
Struman, 2018; Tosar et al., 2015; Wei et al., 2017). Although fragmented noncoding RNAs have historically been considered
degradation products, in many cases the fragments arise from specific processing events. Fragments from tRNAs (tRFs) in
particular are a ubiquitous class of small RNAs reported across diverse organisms both intracellularly and extracellularly. The
fragments are divided into subtypes depending on their biogenesis which can be mediated by Dicer and other RNases includ-
ing angiogenin (S. Li, Xu, & Sheng, 2018). In 2009, one report suggested that tRFs are involved in regulating cell prolifera-
tion in mammalian cells (Y. S. Lee, Shibata, Malhotra, & Dutta, 2009) and several reports since have linked tRF levels inside
of cells to viral infection. For example, it has been shown that tRNA-halves are enriched intracellularly in different viral infec-
tions (Jackowiak et al., 2017; Selitsky et al., 2015; Q. Wang et al., 2013) and might promote RSV replication by repressing
the mRNA of an antiviral host protein in the cytoplasm (Deng et al., 2015; Q. Wang et al., 2013). There are two examples that
viral infections also affect the secretion of tRFs. Zhang et al. (2014) demonstrated increased levels of tRFs in the serum of
patients infected with HBV but did not report a function of the tRFs. Another study reported that tRF-3019, derived from the
30 end of tRNA-proline, was detected in the supernatants of cells infected with human T-cell leukemia virus type 1 (HTLV-1).
There is some evidence that this tRF might enhance viral replication by functioning as a primer for HTLV-1 reverse transcrip-
tase (Ruggero et al., 2014). Although there is still not one specific model for how and why tRNA fragments function in extra-
cellular signaling processes, they have also recently been linked to immune activation as there are preferentially exported in
EVs from T cells and regulate T cell activation (Chiou, Kageyama, & Ansel, 2018). Furthermore, tRNA and rRNA fragments
are produced by a broad range of organisms and have been indicated to be important in the context of other parasite–host and
microbial–host interactions (X. He et al., 2018; Lambertz et al., 2015).
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Further progress in understanding the functions of these noncoding RNA fragments will require modifications to current
technical and bioinformatics methodologies. For example, rRNA-derived fragments (rRFs) are either depleted during library
preparation or discarded in small RNA-seq analysis (Kopylova, Noé, & Touzet, 2012; Schmieder, Lim, & Edwards, 2012;
Y. Wang, Li, Sun, & Yao, 2016). This makes it difficult to estimate the proportion of rRFs in EVs. However, a recent study
on EVs from human glioma stem cells has found that even in rRNA-depleted libraries these rRNA fragments make up to one
third of the reads, indicating that rRNAs are a dominant component of some EVs (Wei et al., 2017). Only recently, scientists
have started to investigate in more detail rRNAs inside the cell and found some evidence for specific processing of rRNA frag-
ments in plants, ticks, and humans (Asha & Soniya, 2017; Z. Chen et al., 2017; Y. Wang, et al., 2016). Although tRFs have
been reported as a dominant class of RNA in EVs (Nolte-'t Hoen et al., 2012), these are also enriched in the nonvesicular frac-
tions of body fluids and cell culture media, which raises the question of how these can be protected from degradation
(Ruggero et al., 2014; Tosar et al., 2015, 2018; Zhang et al., 2014). There is some evidence that the tRFs are bound to ribonu-
cleoproteins (Tosar et al., 2015) and they have also been recently reported to exist as stable dimers (Tosar et al., 2018).
Further work on the functions of rRNA and tRNA fragments inside the cells will help create a framework for why and
how specific sequences are exported and whether this could be used by viruses or the host defense system. Assuming the
export of certain small RNA species from a cell has an important functional role, it is expected that this process would be con-
trolled, and perhaps targeted, by the virus. There is still little understanding on small RNA export and uptake mechanisms but
this is an area of active investigation.
8 | RNA EXPORT MECHANISMS
Extracellular RNA is found outside of cells either protected in EVs or bound to proteins including AGO or high density lipo-
proteins (Fritz et al., 2016; Sohel, 2016). Therefore, it is generally expected that RNA can be released from cells in association
with different complexes, yet the only export mechanism that is understood in any detail is the release of EVs (Figure 4). As
described above, the main classes of EVs originate from plasma membranes or the endocytic pathway and both have been
shown to contain RNA (Crescitelli et al., 2013). Comparative RNA profiling studies revealed that intracellular and extracellu-
lar RNA content is different in some cell types and contexts (Mateescu et al., 2017) leading to interest in what dictates
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FIGURE 4 Release and uptake mechanisms of RNA via extracellular vesicles (EVs). EVs containing RNAs can be released from cells either
through budding from the plasma membrane or through endosomal pathways involving the multivesicular endosomes (MVEs). Uptake mechanisms
in the target cells include fusion with the plasma membrane, phagocytosis or macropinocytosis, (receptor-mediated) endocytosis, clathrin-dependent
endocytosis, caveolin-mediated endocytosis, and endocytosis involving filopodia. The mechanism for secretion of small RNAs independent of EVs
but in association with RNA-binding proteins (RBPs) is still unknown (black box)
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selectivity. Several studies support a model of selective loading of miRNAs into EVs based on sequence recognition by RNA
binding proteins, including motifs within the mature sequence such as the EXOmotif GGAG sequence in miR-601 that is rec-
ognized by the heterogeneous nuclear ribonucleoprotein A2B1 (hnRNPA2B1) in T cells (Villarroya-Beltri et al., 2013) or the
GGCU/A motif recognized by the RNA-binding protein (RBP) SYNCRIP in hepatocytes (Hobor et al., 2018; Santangelo
et al., 2016). It has also been shown that miRNAs in EVs show enrichment for nontemplated 30 end uridylation, compared to
cellular miRNAs, but it is not yet known whether this modification represents an active sorting mechanism (Koppers-Lalic
et al., 2014). In addition, the AGO proteins may play a role in miRNA export under certain conditions as phosphorylation of
AGO2 prevents its packaging into EVs and this has been shown to influences the levels of specific miRNAs in EVs
(McKenzie et al., 2016).
9 | UPTAKE MECHANISMS OF EV-RNA: COMMONALITIES WITH VIRUSES
Just as there is a variety of export vehicles for extracellular RNA that includes EVs, RBPs and lipoproteins, it is expected that
there are different routes to cross the plasma membrane (Figure 4). However, all of the literature on RNA import into mamma-
lian cells has focused on uptake of EVs. In this context, since EVs and viruses both deliver bioactive material to target cells it
is not surprising that there are many overlaps in the pathways involved in export and uptake. Similar to viral tropism, targeted
cell uptake of EV-associated extracellular RNA may be dependent on specific interactions between receptors/recognition mol-
ecules on the plasma membrane and adhesion molecules enriched on the surface of EVs. A vast array of proteins, lipids and
glycans have been implicated in EV-cell target interactions including tetraspanins, integrins, extracellular matrix components,
immunoglobulins, proteoglycans, and lectins (French, Antonyak, & Cerione, 2017; Mulcahy, Pink, & Carter, 2014; Schorey,
Cheng, Singh, & Smith, 2015; van Dongen et al., 2016). There is intriguing data to suggest integrins in particular enable
tumor-derived EVs to target-specific recipient cells within a tissue, thereby providing a mechanism of priming specific organs
for metastatic invasion (Hoshino et al., 2015). To date, it is not known whether different repertoires of adhesion molecules pre-
sent on EV subpopulations (viral or host) lead to selective uptake by particular cells during infection, but given the precedent
in cancer studies, it is certainly possible.
After target cell binding, internalization of EV cargo can be achieved by direct fusion with the plasma membrane (Del
Conde, Shrimpton, Thiagarajan, & López, 2005; Montecalvo et al., 2012; Parolini et al., 2009) or via endocytic pathways
(Montecalvo et al., 2012; Morelli et al., 2004; Svensson et al., 2013; Tian et al., 2014). Live cell imaging studies in human
melanoma cells using EVs labeled with a general lipophilic dye (R18) showed that at least some vesicles are able to fuse with
recipient cells and this was enhanced at acidic pHs (Parolini et al., 2009). There are a number of examples of viruses exploi-
ting direct fusion with the plasma membrane for uptake of their genomes (van Dongen et al., 2016). Direct fusion might pro-
vide distinct pathways for RNA transfer and function compared to endocytic pathways. At the same time, experimental
evidence across many cell types suggests endocytosis is a major route of uptake of both EVs (Costa Verdera, Gitz-Francois,
Schiffelers, & Vader, 2017) and viruses (Mercer, Schelhaas, & Helenius, 2010) while phagocytosis may be used by special-
ized immune cells (e.g., DCs and macrophages) to internalize EVs (Feng et al., 2010; Rudt & Müller, 1993). Internalization
can also occur via macropinocytosis (Fitzner et al., 2011; Nakase, Kobayashi, Takatani-Nakase, & Yoshida, 2015), clathrin-
dependent (Escrevente, Keller, Altevogt, & Costa, 2011; Tian et al., 2014) as well as clathrin-independent mechanisms (Costa
Verdera et al., 2017) or caveolin-dependent endocytosis, which involves internalization of specialized micro-domains called
rafts (lipid or caveolae) (Nanbo, Kawanishi, Yoshida, & Yoshiyama, 2013). One recent paper demonstrated that single EVs
are recruited to cell bodies by surfing on filopodia that enable them to reach endocytic hot spots (Heusermann et al., 2016).
This strategy is also used by viruses, which may have actually evolved to exploit these components of EV uptake pathways.
This work went on to trace the subcellular fate of EVs inside of cells, providing evidence that they associate with the ER, a
site shown to be important for potent RNA silencing of miRNAs and siRNAs (Li et al., 2013; Stalder et al., 2013).
10 | METHODS FOR VISUALIZATION OF EVs AND TRACKING OF
FUNCTIONAL EXTRACELLULAR RNA TRANSPORT IN VIVO
To date the above example is one of only a few reports providing information on the subcellular localization of EVs following
internalization in recipient cells. Advances in single molecular imaging technologies and EV labeling strategies will continue to
be important to advance the field, as well as studies under physiologically relevant conditions. Novel mouse transgenic
approaches have recently provided compelling evidence for transfer of RNA between via EVs in vivo. The Cre-loxP transgenic
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mouse system was used by Stefan Momma's group to show direct transfer of EVs containing Cre mRNA from the blood to the
brain in response to inflammation (Ridder et al., 2014). In this model, the Cre recombinase is specifically expressed in hemato-
poietic cells which were shown to release EVs containing Cre recombinase mRNA (Ridder et al., 2014, 2015) that were taken
up by target cells and led to the expression of a Cre-inducible reporter gene. Although the efficiency of recombination in neurons
was low under normal condition, there was an increase in response to inflammation which may indicate that EV-mediated trans-
fer is important during certain disease states. This approach has also been recently used to visualize EV transfer between cancer
cells using a color switch assay, where DsRed+ tumor cells are converted to eGFP+ tumor cells upon uptake of tumor EVs con-
tain CRE mRNA (Zomer et al., 2015; Zomer, Steenbeek, Maynard, & van Rheenen, 2016). The universal use of the Cre-loxP
system/reporter system and the possibility that other cell types may also use EV-mediated transfer of Cre mRNA offers new ave-
nues to study how EV uptake is mediated and controlled in vivo. However, there is a need for better tools to visualize small
RNA trafficking in vivo, and there is no literature to date visualizing their movement in an organism under physiological condi-
tions. In the absence of tools to study small RNA transfer within an organism, studies of cross-species RNA transfer may provide
novel insights to the field. Here, the transferred RNA can be distinguished through sequencing. For example, using a humanized
transgenic mouse model expressing the entire primate-specific C19MC miRNA cluster or individual miRNAs in the placenta,
the Sadovsky group where able to show extracellular RNA transport between maternal and fetal compartments in vivo (Chang
et al., 2017). It could be envisaged that such a model could be adapted to shed light on the role of this locus in viral infection
when ectopically expressed in nonplacenta cells (see Section 5.2).
11 | CHALLENGES WHEN STUDYING EXTRACELLULAR RNA IN VIRAL
INFECTIONS
A key hurdle in the field is purifying sufficient quantities and homogenous populations of EVs for functional studies. Many
strategies are now focused on this aspect, which is reviewed further in Konoshenko et al. (2018) In particular,
immunopurification strategies targeting surface EV proteins and cushioned density gradient ultracentrifugation (cushioned-
DGUC) techniques are gaining popularity (K. Li, Wong, Hong, & Raffai et al., 2018). Other interesting and novel approaches
include Contact Free-Sorting using acoustic waves to fractionate EVs based on size and density (K. Lee, Shao, Weissleder, &
Lee, 2015; M. Wu et al., 2017). Isolating EVs from cell culture media also comes with a range of challenges and extensive
energy from the community has focused on “best practice” to avoid EV damage and artifacts associated with the purification
methods. An overview of guidelines, advantages and disadvantages of purification approaches is provided in the minimal
information for studies of extracellular vesicles 2018 report (Théry et al., 2018). However, this is further complicated when
isolating EVs from cells infected with viruses since EVs and virions display similar sizes and biochemical compositions such
that commonly used isolation methods will result in a mixed population of EVs and virions (Raab-Traub & Dittmer, 2017).
Affinity purification using magnetic beads against specific EV membrane proteins like CD63 can help separate EVs from
some virions but selects for a subpopulation of EVs, as not all EVs express the same markers on their surface (Kowal et al.,
2016). This becomes further complicated by the fact that several viruses use the same host secretion routes as vesicles. For
example, IAV was shown to incorporate CD9 into virions (Hutchinson et al., 2014), while HBV envelope proteins colocalize
with MVE proteins ALIX and VPS4B (Watanabe et al., 2007). Other host proteins that are used as EV markers, including
Annexin 2 and heat shock proteins, were found in HIV-1 virions (Linde et al., 2013). Early studies have shown that even
CD63, a classical EV marker, is incorporated by HIV-1 virions (Meerloo et al., 1993; Orentas & Hildreth, 1993) and this fur-
ther underscores the difficulty of finding a universal marker to separate EVs from viruses. Accordingly, it is important to note
that not only EV purifications are contaminated by viruses but also vice versa, as most virus purification protocols do not
deplete EVs, something that has been recognized for many years in the HIV field (Bess, Gorelick, Bosche, Henderson, &
Arthur, 1997; Gluschankof, Mondor, Gelderblom, & Sattentau, 1997). Dettenhofer & Yu (1999) were the first to address this
issue by developing an OptiPrep velocity gradient to separate HIV particles from EVs in order to characterize the protein pro-
file of the virions. On this note, a range of studies have characterized cellular noncoding RNAs in virions, including small
RNAs (Eckwahl, Telesnitsky, & Wolin, 2016) and further work may be required to understand whether these are solely pack-
aged in virions or the EVs with which they co-purify.
Another major issue in EV purifications is contaminants from the culture media in the case of in vitro studies (Tosar et al.,
2017) or from different body fluids in the case of in vivo studies (Gyorgy et al., 2011; Théry, Amigorena, Raposo, & Clayton,
2006). Many cells depend on culture media containing animal-derived serum, including fetal bovine serum, which is known
to comprise bovine EVs containing RNA, as well as nonvesicular complexes containing small RNAs (Tosar et al., 2017). To
study EVs and/or extracellular RNA, the standard technique is to use vesicle-depleted media. Vesicle depletion is usually
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achieved by prolonged ultracentrifugation of the diluted serum (Shelke, Lässer, Gho, & Lötvall, 2014; Théry et al., 2006) but
it has been shown that this is not sufficient to remove EVs completely (Lehrich, Liang, Khosravi, Federoff, & Fiandaca, 2018;
Wei, Batagov, Carter, & Krichevsky, 2016). In addition, the depletion of vesicles from the culture media can alter cell prolifer-
ation (Eitan, Zhang, Witwer, & Mattson, 2015). Given the importance and breadth of the extracellular RNA field, there is sub-
stantial energy focused on addressing these issues and bringing new tools to this research (Carpintero-Fernández, Fafián-
Labora, & O'Loghlen, 2017; Driedonks, Nijen Twilhaar, & Nolte-'t Hoen, 2019).
12 | OUTSTANDING CHALLENGES AND CONCLUSIONS
In summary, the field of extracellular RNA offers many new exciting possibilities for how cells communicate with one
another, and how viruses have evolved to exploit or modulate these mechanisms during their lifecycles. However, there are
many technical challenges and unknowns that come with the youth of this field (Box 1). Sequencing analyses of the RNA
found in different body fluids have dominated this field, with less focus on how the RNA became extracellular and whether it
is directed to a specific target. As such, the field of extracellular RNA has lurked on the fringe of mainstream RNA biology
but recent reports linking selectivity in RNA export with RBPs will hopefully help to integrate extracellular and intracellular
studies. Furthermore, the study of how viruses modulate and hijack RNA export pathways could play an important role in
driving the extracellular RNA field forward, in the same way viruses have helped illuminate fundamental aspects of RNA
processing and gene regulation inside the cell.
However, many technical challenges exist that need to be addressed to move the field forward. In particular, the ability to
study RNA export, including selectivity mechanisms, requires isolation of pure populations of extracellular RNA. We are still
learning what those populations are and they include both vesicular and nonvesicular complexes. In the case of vesicular
RNAs, we know the EVs themselves are heterogenous: cells produce multiple EV subsets whose cargo and functions can dif-
fer (Kowal et al., 2016). In the context of an infected cell, virions themselves also add to this complexity as most current
methods of EV or virus purification will not distinguish the two. To meet these challenges, new technologies are evolving, as
detailed in this review. Given the burgeoning body of data detailing functional properties of extracellular vesicles in mamma-
lian disease, and the implications that RNA underpins some of these functions, it seems worth the challenge.
ACKNOWLEDGMENTS
We thank James Burke and Kyriaki Neophytou for helpful comments on the manuscript. A.H.B. was supported by Wellcome
Trust 097394/Z/11/Z and Wellcome Trust-University of Edinburgh Institutional Strategic Support Fund. A.R. was supported
by University of Medicine and Pharmacy “Carol Davila”, project number 5.780/08.03.2017. S.R. was supported by Darwin
Trust PhD Scholarship.
CONFLICT OF INTEREST
The authors have declared no conflicts of interest for this article.
RELATED WIREs ARTICLE
RNA in extracellular vesicles
ORCID
Amy H. Buck https://orcid.org/0000-0003-2645-7191
REFERENCES
Affo, S., Yu, L.-X., & Schwabe, R. F. (2017). The role of cancer-associated fibroblasts and fibrosis in liver cancer. Annual Review of Pathology, 12,
153–186. https://doi.org/10.1146/annurev-pathol-052016-100322
Alvarez-Garcia, I., & Miska, E. A. (2005). MicroRNA functions in animal development and human disease. Development, 132(21), 4653–4662.
https://doi.org/10.1242/dev.02073
RESSEL ET AL. 15 of 23
Aqil, M., Naqvi, A. R., Mallik, S., Bandyopadhyay, S., Maulik, U., & Jameel, S. (2014). The HIV Nef protein modulates cellular and exosomal
miRNA profiles in human monocytic cells. Journal of Extracellular Vesicles, 3, 23129. https://doi.org/10.3402/jev.v3.23129
Archer, S. J. (1978). Induction of a T-cell specific antigen on bone marrow lymphocytes with thymus RNA. Immunology, 34, 123–129.
Asha, S., & Soniya, E. V. (2017). The sRNAome mining revealed existence of unique signature small RNAs derived from 5.8SrRNA from Piper
nigrum and other plant lineages. Scientific Reports, 7, 41052. https://doi.org/10.1038/srep41052
Azlan, A., Dzaki, N., & Azzam, G. (2016). Argonaute: The executor of small RNA function. Journal of Genetics and Genomics, 43(8), 481–494.
https://doi.org/10.1016/j.jgg.2016.06.002
Backes, S., Shapiro, J. S., Sabin, L. R., Pham, A. M., Reyes, I., Moss, B., … tenOever, B. R. (2012). Degradation of host microRNAs by poxvirus
poly(A) polymerase reveals terminal RNA methylation as a protective antiviral mechanism. Cell Host & Microbe, 12, 200–210. https://doi.org/
10.1016/J.CHOM.2012.05.019
Baglio, S. R., van Eijndhoven, M. A. J., Koppers-Lalic, D., Berenguer, J., Lougheed, S. M., Gibbs, S., … Pegtel, D. M. (2016). Sensing of latent
EBV infection through exosomal transfer of 50pppRNA. Proceedings of the National Academy of Sciences of the United States of America, 113,
E587–E596. https://doi.org/10.1073/pnas.1518130113
Barclay, R. A., Schwab, A., DeMarino, C., Akpamagbo, Y., Lepene, B., Kassaye, S.,… Kashanchi, F. (2017). Exosomes from uninfected cells acti-
vate transcription of latent HIV-1. Journal of Biological Chemistry, 292, 14764. https://doi.org/10.1074/jbc.A117.793521
Bartel, D. P. (2018). Metazoan microRNAs. Cell, 173, 20–51. https://doi.org/10.1016/j.cell.2018.03.006
Baulcombe, D. (2004). RNA silencing in plants. Nature, 431, 356–363. https://doi.org/10.1038/nature02874
Becker, A., Thakur, B. K., Weiss, J. M., Kim, H. S., Peinado, H., & Lyden, D. (2016). Extracellular vesicles in cancer: Cell-to-cell mediators of
metastasis. Cancer Cell, 30, 836–848. https://doi.org/10.1016/J.CCELL.2016.10.009
Bentwich, I., Avniel, A., Karov, Y., Aharonov, R., Gilad, S., Barad, O., … Bentwich, Z. (2005). Identification of hundreds of conserved and non-
conserved human microRNAs. Nature Genetics, 37, 766–770. https://doi.org/10.1038/ng1590
Berkower, I., Spadaccini, A., Chen, H., Al-Awadi, D., Muller, J., Gao, Y.,… Ni, Y. (2011). Hepatitis B virus surface antigen assembly function per-
sists when entire transmembrane domains 1 and 3 are replaced by a heterologous transmembrane sequence. Journal of Virology, 85, 2439–2448.
https://doi.org/10.1128/JVI.02061-10
Bernard, M. A., Zhao, H., Yue, S. C., Anandaiah, A., Koziel, H., & Tachado, S. D. (2014). Novel HIV-1 MiRNAs stimulate TNFα release in human
macrophages via TLR8 signaling pathway. PLoS One, 9, e106006. https://doi.org/10.1371/journal.pone.0106006
Bess, J. W., Jr., Gorelick, R. J., Bosche, W. J., Henderson, L. E., & Arthur, L. O. (1997). Microvesicles are a source of contaminating cellular pro-
teins found in purified HIV-1 preparations. Virology, 230(1), 134–144. https://doi.org/10.1006/viro.1997.8499
Brennecke, J., Stark, A., Russell, R. B., & Cohen, S. M. (2005). Principles of microRNA-target recognition. PLoS Biology, 3(3), e85. https://doi.org/
10.1371/journal.pbio.0030085
Bruscella, P., Bottini, S., Baudesson, C., Pawlotsky, J.-M., Feray, C., & Trabucchi, M. (2017). Viruses and miRNAs: More friends than foes. Fron-
tiers in Microbiology, 8, 824. https://doi.org/10.3389/fmicb.2017.00824
Buck, A. H., Ivens, A., Gordon, K., Craig, N., Houzelle, A., Roche, A., … Stewart, J. P. (2015). Quantitative analysis of microRNAs in Vaccinia
virus infection reveals diversity in their susceptibility to modification and suppression. PLoS One, 10(7), e0131787. https://doi.org/10.1371/
journal.pone.0131787
Bukong, T. N., Momen-Heravi, F., Kodys, K., Bala, S., & Szabo, G. (2014). Exosomes from hepatitis C infected patients transmit HCV infection
and contain replication competent viral RNA in complex with Ago2-miR122-HSP90. PLoS Pathogens, 10, e1004424. https://doi.org/10.1371/
journal.ppat.1004424
Carpintero-Fernández, P., Fafián-Labora, J., & O'Loghlen, A. (2017). Technical advances to study extracellular vesicles. Frontiers in Molecular Bio-
sciences, 4, 79. https://doi.org/10.3389/fmolb.2017.00079
Cazalla, D., Yario, T., Steitz, J. A., & Steitz, J. (2010). Down-regulation of a host microRNA by a herpesvirus saimiri noncoding RNA. Science,
328, 1563–1566. https://doi.org/10.1126/science.1187197
Chahar, H. S., Corsello, T., Kudlicki, A. S., Komaravelli, N., & Casola, A. (2018). Respiratory syncytial virus infection changes cargo composition
of exosome released from airway epithelial cells. Scientific Reports, 8, 387. https://doi.org/10.1038/s41598-017-18672-5
Chai, N., Chang, H. E., Nicolas, E., Han, Z., Jarnik, M., & Taylor, J. (2008). Properties of subviral particles of hepatitis B virus. Journal of Virology,
82(16), 7812–7817. https://doi.org/10.1128/JVI.00561-08
Chang, G., Mouillet, J.-F., Mishima, T., Chu, T., Sadovsky, E., Coyne, C. B.,… Sadovsky, Y. (2017). Expression and trafficking of placental micro-
RNAs at the feto-maternal interface. FASEB Journal, 31, 2760–2770. https://doi.org/10.1096/fj.201601146R
Chen, X., Ba, Y., Ma, L., Cai, X., Yin, Y., Wang, K., … Zhang, C.-Y. (2008). Characterization of microRNAs in serum: A novel class of bio-
markers for diagnosis of cancer and other diseases. Cell Research, 18, 997–1006. https://doi.org/10.1038/cr.2008.282
Chen, Z., Sun, Y., Yang, X., Wu, Z., Guo, K., Niu, X.,… Gao, S. (2017). Two featured series of rRNA-derived RNA fragments (rRFs) constitute a
novel class of small RNAs. PLoS One, 12, e0176458. https://doi.org/10.1371/journal.pone.0176458
Chim, S. S. C., Shing, T. K. F., Hung, E. C. W., Leung, T.-y., Lau, T.-k., Chiu, R. W. K., & Dennis Lo, Y. M. (2008). Detection and characteriza-
tion of placental microRNAs in maternal plasma. Clinical Chemistry, 54, 482–490. https://doi.org/10.1373/clinchem.2007.097972
Chiou, N. T., Kageyama, R., & Ansel, K. M. (2018). Selective export into extracellular vesicles and function of tRNA fragments during T cell acti-
vation. Cell Reports, 25(12), 3356–3370.e3354. https://doi.org/10.1016/j.celrep.2018.11.073
Chivero, E. T., Bhattarai, N., Rydze, R. T., Winters, M. A., Holodniy, M., & Stapleton, J. T. (2014). Human pegivirus RNA is found in multiple
blood mononuclear cells in vivo and serum-derived viral RNA-containing particles are infectious in vitro. Journal of General Virology, 95,
1307–1319. https://doi.org/10.1099/vir.0.063016-0
16 of 23 RESSEL ET AL.
Colombo, M., Raposo, G., & Théry, C. (2014). Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles.
Annual Review of Cell and Developmental Biology, 30, 255–289. https://doi.org/10.1146/annurev-cellbio-101512-122326
Columba Cabezas, S., & Federico, M. (2013). Sequences within RNA coding for HIV-1 Gag p17 are efficiently targeted to exosomes. Cellular
Microbiology, 15, 412–429. https://doi.org/10.1111/cmi.12046
Cosset, F.-L., & Dreux, M. (2014). HCV transmission by hepatic exosomes establishes a productive infection. Journal of Hepatology, 60, 674–675.
https://doi.org/10.1016/J.JHEP.2013.10.015
Costa Verdera, H., Gitz-Francois, J. J., Schiffelers, R. M., & Vader, P. (2017). Cellular uptake of extracellular vesicles is mediated by clathrin-
independent endocytosis and macropinocytosis. Journal of Controlled Release, 266, 100–108. https://doi.org/10.1016/J.JCONREL.2017.09.019
Crescitelli, R., Lässer, C., Szabó, T. G., Kittel, A., Eldh, M., Dianzani, I., … Lötvall, J. (2013). Distinct RNA profiles in subpopulations of extracel-
lular vesicles: Apoptotic bodies, microvesicles and exosomes. Journal of Extracellular Vesicles, 2, 20677. https://doi.org/10.3402/jev.v2i0.
20677
Cullen, B. R. (2006). Viruses and microRNAs. Nature Genetics, 38, S25–S30. https://doi.org/10.1038/ng1793
de Candia, P., De Rosa, V., Casiraghi, M., & Matarese, G. (2016). Extracellular RNAs: A secret arm of immune system regulation. Journal of Bio-
logical Chemistry, 291, 7221–7228. https://doi.org/10.1074/jbc.R115.708842
De Toro, J., Herschlik, L., Waldner, C., & Mongini, C. (2015). Emerging roles of exosomes in normal and pathological conditions: New insights for
diagnosis and therapeutic applications. Frontiers in Immunology, 6, 203. https://doi.org/10.3389/fimmu.2015.00203
Del Conde, I., Shrimpton, C. N., Thiagarajan, P., & López, J. A. (2005). Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with acti-
vated platelets to initiate coagulation. Blood, 106, 1604–1611. https://doi.org/10.1182/blood-2004-03-1095
Delorme-Axford, E., Donker, R. B., Mouillet, J.-F., Chu, T., Bayer, A., Ouyang, Y., … Coyne, C. B. (2013). Human placental trophoblasts confer
viral resistance to recipient cells. Proceedings of the National Academy of Sciences of the United States of America, 110, 12048–12053. https://
doi.org/10.1073/pnas.1304718110
Deng, J., Ptashkin, R. N., Chen, Y., Cheng, Z., Liu, G., Phan, T., … Bao, X. (2015). Respiratory syncytial virus utilizes a tRNA fragment to sup-
press antiviral responses through a novel targeting mechanism. Molecular Therapy, 23(10), 1622–1629. https://doi.org/10.1038/mt.2015.124
Dettenhofer, M., & Yu, X. F. (1999). Highly purified human immunodeficiency virus type 1 reveals a virtual absence of Vif in virions. Journal of
Virology, 73(2), 1460–1467.
Devhare, P. B., Sasaki, R., Shrivastava, S., Di Bisceglie, A. M., Ray, R., & Ray, R. B. (2017). Exosome-mediated intercellular communication
between hepatitis C virus-infected hepatocytes and hepatic stellate cells. Journal of Virology, 91, e02225–02216. https://doi.org/10.1128/JVI.
02225-16
Ding, S.-W., Han, Q., Wang, J., & Li, W.-X. (2018). Antiviral RNA interference in mammals. Current Opinion in Immunology, 54, 109–114.
https://doi.org/10.1016/J.COI.2018.06.010
Ding, S.-W., & Voinnet, O. (2007). Antiviral immunity directed by small RNAs. Cell, 130, 413–426. https://doi.org/10.1016/J.CELL.2007.07.039
Donker, R. B., Mouillet, J. F., Chu, T., Hubel, C. A., Stolz, D. B., Morelli, A. E., & Sadovsky, Y. (2012). The expression profile of C19MC micro-
RNAs in primary human trophoblast cells and exosomes. Molecular Human Reproduction, 18, 417–424. https://doi.org/10.1093/molehr/gas013
Dreux, M., Garaigorta, U., Boyd, B., Décembre, E., Chung, J., Whitten-Bauer, C., … Chisari, F. V. (2012). Short-range exosomal transfer of viral
RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity. Cell Host & Microbe, 12, 558–570. https://doi.org/10.1016/J.
CHOM.2012.08.010
Driedonks, T. A. P., Nijen Twilhaar, M. K., & Nolte-'t Hoen, E. N. M. (2019). Technical approaches to reduce interference of fetal calf serum
derived RNA in the analysis of extracellular vesicle RNA from cultured cells. Journal of Extracellular Vesicles, 8(1), 1552059. https://doi.org/
10.1080/20013078.2018.1552059
Driedonks, T. A. P., & Nolte-'t Hoen, E. N. M. (2018). Circulating Y-RNAs in extracellular vesicles and ribonucleoprotein complexes; implications
for the immune system. Frontiers in Immunology, 9, 3164. https://doi.org/10.3389/fimmu.2018.03164
Driedonks, T. A. P., van der Grein, S. G., Ariyurek, Y., Buermans, H. P. J., Jekel, H., Chow, F. W. N., … Nolte-'t Hoen, E. N. M. (2018). Immune
stimuli shape the small non-coding transcriptome of extracellular vesicles released by dendritic cells. Cellular and Molecular Life Sciences, 75
(20), 3857–3875. https://doi.org/10.1007/s00018-018-2842-8
Eckwahl, M. J., Telesnitsky, A., & Wolin, S. L. (2016). Host RNA packaging by retroviruses: A newly synthesized story. MBio, 7, e02025-15.
https://doi.org/10.1128/mBio.02025-15
Eitan, E., Zhang, S., Witwer, K. W., & Mattson, M. P. (2015). Extracellular vesicle-depleted fetal bovine and human sera have reduced capacity to
support cell growth. Journal of Extracellular Vesicles, 4, 26373. https://doi.org/10.3402/jev.v4.26373
Escrevente, C., Keller, S., Altevogt, P., & Costa, J. (2011). Interaction and uptake of exosomes by ovarian cancer cells. BMC Cancer, 11, 108.
https://doi.org/10.1186/1471-2407-11-108
Fabbri, M., Paone, A., Calore, F., Galli, R., & Croce, C. M. (2013). A new role for microRNAs, as ligands of toll-like receptors. RNA Biology, 10
(2), 169–174. https://doi.org/10.4161/rna.23144
Feng, D., Zhao, W.-L., Ye, Y.-Y., Bai, X.-C., Liu, R.-Q., Chang, L.-F., … Sui, S.-F. (2010). Cellular internalization of exosomes occurs through
phagocytosis. Traffic, 11, 675–687. https://doi.org/10.1111/j.1600-0854.2010.01041.x
Fishman, M., Hammerstrom, R. A., & Bond, V. P. (1963). In vitro transfer of macrophage RNA to lymph node cells. Nature, 198, 549–551. https://
doi.org/10.1038/198549a0
Fitzner, D., Schnaars, M., van Rossum, D., Krishnamoorthy, G., Dibaj, P., Bakhti, M., … Simons, M. (2011). Selective transfer of exosomes from
oligodendrocytes to microglia by macropinocytosis. Journal of Cell Science, 124, 447–458. https://doi.org/10.1242/jcs.074088
RESSEL ET AL. 17 of 23
French, K. C., Antonyak, M. A., & Cerione, R. A. (2017). Extracellular vesicle docking at the cellular port: Extracellular vesicle binding and uptake.
Seminars in Cell & Developmental Biology, 67, 48–55. https://doi.org/10.1016/J.SEMCDB.2017.01.002
Fritz, J. V., Heintz-Buschart, A., Ghosal, A., Wampach, L., Etheridge, A., Galas, D., & Wilmes, P. (2016). Sources and functions of extracellular
small RNAs in human circulation. Annual Review of Nutrition, 36, 301–336. https://doi.org/10.1146/annurev-nutr-071715-050711
Fruci, D., Rota, R., & Gallo, A. (2017). The role of HCMV and HIV-1 microRNAs: Processing, and mechanisms of action during viral infection.
Frontiers in Microbiology, 8, 689. https://doi.org/10.3389/fmicb.2017.00689
Fu, Y., Zhang, L., Zhang, F., Tang, T., Zhou, Q., Feng, C., … Wu, Z. (2017). Exosome-mediated miR-146a transfer suppresses type I interferon
response and facilitates EV71 infection. PLoS Pathogens, 13, e1006611. https://doi.org/10.1371/journal.ppat.1006611
Girardi, E., López, P., & Pfeffer, S. (2018). On the importance of host microRNAs during viral infection. Frontiers in Genetics, 9, 439.
https://doi.org/10.3389/fgene.2018.00439
Gluschankof, P., Mondor, I., Gelderblom, H. R., & Sattentau, Q. J. (1997). Cell membrane vesicles are a major contaminant of gradient-enriched
human immunodeficiency virus type-1 preparations. Virology, 230(1), 125–133. https://doi.org/10.1006/viro.1997.8453
Gottwein, E., & Cullen, B. R. (2010). A human herpesvirus microRNA inhibits p21 expression and attenuates p21-mediated cell cycle arrest. Jour-
nal of Virology, 84, 5229–5237. https://doi.org/10.1128/JVI.00202-10
Gould, S. J., Booth, A. M., & Hildreth, J. E. K. (2003). The Trojan exosome hypothesis. Proceedings of the National Academy of Sciences, 100,
10592–10597. https://doi.org/10.1073/pnas.1831413100
Grey, F. (2015). Role of microRNAs in herpesvirus latency and persistence. Journal of General Virology, 96, 739–751. https://doi.org/10.1099/vir.
0.070862-0
Guo, Y. E., Oei, T., & Steitz, J. A. (2015). Herpesvirus saimiri microRNAs preferentially target host cell cycle regulators. Journal of Virology, 89,
10901–10911. https://doi.org/10.1128/JVI.01884-15
Guo, Y. E., Riley, K. J., Iwasaki, A., & Steitz, J. A. (2014). Alternative capture of noncoding RNAs or protein-coding genes by herpesviruses to alter
host T cell function. Molecular Cell, 54, 67–79. https://doi.org/10.1016/J.MOLCEL.2014.03.025
Gyorgy, B., Modos, K., Pallinger, E., Paloczi, K., Pasztoi, M., Misjak, P.,… Buzas, E. I. (2011). Detection and isolation of cell-derived microparti-
cles are compromised by protein complexes resulting from shared biophysical parameters. Blood, 117(4), e39–e48. https://doi.org/10.1182/
blood-2010-09-307595
Ha, M., & Kim, V. N. (2014). Regulation of microRNA biogenesis. Nature Reviews Molecular Cell Biology, 15, 509–524. https://doi.org/10.1038/
nrm3838
Hamilton, A. J., & Baulcombe, D. C. (1999). A species of small antisense RNA in posttranscriptional gene silencing in plants. Science, 286,
950–952.
Hannon, G. J. (2002). RNA interference. Nature, 418, 244–251. https://doi.org/10.1038/418244a
Harwig, A., Jongejan, A., van Kampen, A. H. C., Berkhout, B., & Das, A. T. (2016). Tat-dependent production of an HIV-1 TAR-encoded miRNA-
like small RNA. Nucleic Acids Research, 44, 4340–4353. https://doi.org/10.1093/nar/gkw167
He, G., & Karin, M. (2011). NF-κB and STAT3—Key players in liver inflammation and cancer. Cell Research, 21, 159–168. https://doi.org/10.
1038/cr.2010.183
He, X., Li, F., Bor, B., Koyano, K., Cen, L., Xiao, X., …Wong, D. T. W. (2018). Human tRNA-derived small RNAs modulate host–oral microbial
interactions. Journal of Dental Research, 97, 1236–1243. https://doi.org/10.1177/0022034518770605
Heermann, K. H., Goldmann, U., Schwartz, W., Seyffarth, T., Baumgarten, H., & Gerlich, W. H. (1984). Large surface proteins of hepatitis B virus
containing the pre-s sequence. Journal of Virology, 52, 396–402.
Heusermann, W., Hean, J., Trojer, D., Steib, E., von Bueren, S., Graff-Meyer, A., … Meisner-Kober, N. C. (2016). Exosomes surf on filopodia to
enter cells at endocytic hot spots, traffic within endosomes, and are targeted to the ER. Journal of Cell Biology, 213, 173–184. https://doi.org/10.
1083/jcb.201506084
Ho, B.-C., Yu, I.-S., Lu, L.-F., Rudensky, A., Chen, H.-Y., Tsai, C.-W., … Yu, S.-L. (2014). Inhibition of miR-146a prevents enterovirus-induced
death by restoring the production of type I interferon. Nature Communications, 5, 3344. https://doi.org/10.1038/ncomms4344
Hobor, F., Dallmann, A., Ball, N. J., Cicchini, C., Battistelli, C., Ogrodowicz, R. W.,… Ramos, A. (2018). A cryptic RNA-binding domain mediates
Syncrip recognition and exosomal partitioning of miRNA targets. Nature Communications, 9(1), 831. https://doi.org/10.1038/s41467-018-
03182-3
Hoshino, A., Costa-Silva, B., Shen, T.-L., Rodrigues, G., Hashimoto, A., Tesic Mark, M., … Lyden, D. (2015). Tumour exosome integrins deter-
mine organotropic metastasis. Nature, 527, 329–335. https://doi.org/10.1038/nature15756
Hoy, A. M., & Buck, A. H. (2012). Extracellular small RNAs: What, where, why? Biochemical Society Transactions, 40, 886–890. https://doi.org/
10.1042/BST20120019
Hsu, A. C.-Y., Dua, K., Starkey, M. R., Haw, T.-J., Nair, P. M., Nichol, K.,…Wark, P. A. (2017). MicroRNA-125a and -b inhibit A20 and MAVS
to promote inflammation and impair antiviral response in COPD. JCI Insight, 2, e90443. https://doi.org/10.1172/jci.insight.90443
Hutchinson, E. C., Charles, P. D., Hester, S. S., Thomas, B., Trudgian, D., Martínez-Alonso, M., & Fodor, E. (2014). Conserved and host-specific
features of influenza virion architecture. Nature Communications, 5, 4816. https://doi.org/10.1038/ncomms5816
Jackowiak, P., Hojka-Osinska, A., Philips, A., Zmienko, A., Budzko, L., Maillard, P., … Figlerowicz, M. (2017). Small RNA fragments derived
from multiple RNA classes—The missing element of multi-omics characteristics of the hepatitis C virus cell culture model. BMC Genomics, 18,
502. https://doi.org/10.1186/s12864-017-3891-3
18 of 23 RESSEL ET AL.
Jaworski, E., Narayanan, A., Van Duyne, R., Shabbeer-Meyering, S., Iordanskiy, S., Saifuddin, M., … Kashanchi, F. (2014). Human T-
lymphotropic virus type 1-infected cells secrete exosomes that contain Tax protein. Journal of Biological Chemistry, 289, 22284–22305. https://
doi.org/10.1074/jbc.M114.549659
Jopling, C. L., Yi, M., Lancaster, A. M., Lemon, S. M., & Sarnow, P. (2005). Modulation of hepatitis C virus RNA abundance by a liver-specific
microRNA. Science, 309, 1577–1581. https://doi.org/10.1126/science.1113329
Kincaid, R. P., & Sullivan, C. S. (2012). Virus-encoded microRNAs: An overview and a look to the future. PLoS Pathogens, 8, e1003018. https://
doi.org/10.1371/journal.ppat.1003018
Klase, Z., Kale, P., Winograd, R., Gupta, M. V., Heydarian, M., Berro, R., … Kashanchi, F. (2007). HIV-1 TAR element is processed by dicer to
yield a viral micro-RNA involved in chromatin remodeling of the viral LTR. BMC Molecular Biology, 8, 63. https://doi.org/10.1186/1471-2199-
8-63
Klase, Z., Winograd, R., Davis, J., Carpio, L., Hildreth, R., Heydarian, M., … Kashanchi, F. (2009). HIV-1 TAR miRNA protects against apoptosis
by altering cellular gene expression. Retrovirology, 6, 18. https://doi.org/10.1186/1742-4690-6-18
Kolodny, G. M. (1971). Evidence for transfer of macromolecular RNA between mammalian cells in culture. Experimental Cell Research, 65,
313–324.
Kolodny, G. M. (1972). Cell to cell transfer of RNA into transformed cells. Journal of Cellular Physiology, 79, 147–150. https://doi.org/10.1002/
jcp.1040790117
Konoshenko, M. Y., Lekchnov, E. A., Vlassov, A. V., & Laktionov, P. P. (2018). Isolation of extracellular vesicles: General methodologies and lat-
est trends. BioMed Research International, 2018, 1–27. https://doi.org/10.1155/2018/8545347
Koppers-Lalic, D., Hackenberg, M., Bijnsdorp, I. V., van Eijndhoven, M. A. J., Sadek, P., Sie, D.,… Pegtel, D. M. (2014). Nontemplated nucleotide
additions distinguish the small RNA composition in cells from exosomes. Cell Reports, 8, 1649–1658. https://doi.org/10.1016/J.CELREP.2014.
08.027
Kopylova, E., Noé, L., & Touzet, H. (2012). SortMeRNA: Fast and accurate filtering of ribosomal RNAs in metatranscriptomic data. Bioinformatics,
28, 3211–3217. https://doi.org/10.1093/bioinformatics/bts611
Kouwaki, T., Fukushima, Y., Daito, T., Sanada, T., Yamamoto, N., Mifsud, E. J.,… Oshiumi, H. (2016). Extracellular vesicles including exosomes
regulate innate immune responses to hepatitis B virus infection. Frontiers in Immunology, 7, 335. https://doi.org/10.3389/fimmu.2016.00335
Kouwaki, T., Okamoto, M., Tsukamoto, H., Fukushima, Y., & Oshiumi, H. (2017). Extracellular vesicles deliver host and virus RNA and regulate
innate immune response. International Journal of Molecular Sciences, 18, 666. https://doi.org/10.3390/ijms18030666
Kowal, J., Arras, G., Colombo, M., Jouve, M., Morath, J. P., Primdal-Bengtson, B., … Théry, C. (2016). Proteomic comparison defines novel
markers to characterize heterogeneous populations of extracellular vesicle subtypes. Proceedings of the National Academy of Sciences, 113,
E968–E977. https://doi.org/10.1073/pnas.1521230113
Laganà, A., Russo, F., Veneziano, D., Bella, S. D., Giugno, R., Pulvirenti, A., … Ferro, A. (2013). Extracellular circulating viral microRNAs: Cur-
rent knowledge and perspectives. Frontiers in Genetics, 4, 120. https://doi.org/10.3389/fgene.2013.00120
Lambertz, U., Oviedo Ovando, M. E., Vasconcelos, E., Unrau, P. J., Myler, P. J., & Reiner, N. E. (2015). Small RNAs derived from tRNAs and
rRNAs are highly enriched in exosomes from both old and new world Leishmania providing evidence for conserved exosomal RNA packaging.
BMC Genomics, 16, 151. https://doi.org/10.1186/s12864-015-1260-7
Lässer, C., Shelke, G. V., Yeri, A., Kim, D.-K., Crescitelli, R., Raimondo, S., … Lötvall, J. (2017). Two distinct extracellular RNA signatures
released by a single cell type identified by microarray and next-generation sequencing. RNA Biology, 14, 58–72. https://doi.org/10.1080/
15476286.2016.1249092
Lawrie, C. H., Gal, S., Dunlop, H. M., Pushkaran, B., Liggins, A. P., Pulford, K., … Harris, A. L. (2008). Detection of elevated levels of tumour-
associated microRNAs in serum of patients with diffuse large B-cell lymphoma. British Journal of Haematology, 141, 672–675. https://doi.org/
10.1111/j.1365-2141.2008.07077.x
Lee, K., Shao, H., Weissleder, R., & Lee, H. (2015). Acoustic purification of extracellular microvesicles. ACS Nano, 9, 2321–2327. https://doi.org/
10.1021/nn506538f
Lee, Y. S., Shibata, Y., Malhotra, A., & Dutta, A. (2009). A novel class of small RNAs: tRNA-derived RNA fragments (tRFs). Genes & Develop-
ment, 23, 2639–2649. https://doi.org/10.1101/gad.1837609
Lehrich, B. M., Liang, Y., Khosravi, P., Federoff, H. J., & Fiandaca, M. S. (2018). Fetal bovine serum-derived extracellular vesicles persist within
vesicle-depleted culture media. International Journal of Molecular Sciences, 19(11), 3538. https://doi.org/10.3390/ijms19113538
Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes
are microRNA targets. Cell, 120, 15–20. https://doi.org/10.1016/J.CELL.2004.12.035
Lewis, B. P., Shih, I. H., Jones-Rhoades, M. W., Bartel, D. P., & Burge, C. B. (2003). Prediction of mammalian microRNA targets. Cell, 115(7),
787–798.
Li, K., Wong, D. K., Hong, K. Y., & Raffai, R. L. (2018). Cushioned-density gradient ultracentrifugation (C-DGUC): A refined and high perfor-
mance method for the isolation, characterization, and use of exosomes. Methods in Molecular Biology, 1740, 69–83. https://doi.org/10.1007/
978-1-4939-7652-2_7
Li, S., Liu, L., Zhuang, X., Yu, Y., Liu, X., Cui, X., … Chen, X. (2013). MicroRNAs inhibit the translation of target mRNAs on the endoplasmic
reticulum in Arabidopsis. Cell, 153(3), 562–574. https://doi.org/10.1016/j.cell.2013.04.005
Li, S., Xu, Z., & Sheng, J. (2018). tRNA-derived small RNA: A novel regulatory small non-coding RNA. Genes, 9, 246. https://doi.org/10.3390/
GENES9050246
RESSEL ET AL. 19 of 23
Libri, V., Helwak, A., Miesen, P., Santhakumar, D., Borger, J. G., Kudla, G., … Buck, A. H. (2012). Murine cytomegalovirus encodes a miR-27
inhibitor disguised as a target. Proceedings of the National Academy of Sciences of the United States of America, 109, 279–284. https://doi.org/
10.1073/pnas.1114204
Linde, M. E., Colquhoun, D. R., Ubaida Mohien, C., Kole, T., Aquino, V., Cotter, R., … Graham, D. R. (2013). The conserved set of host proteins
incorporated into HIV-1 Virions suggests a common egress pathway in multiple cell types. Journal of Proteome Research, 12, 2045–2054.
https://doi.org/10.1021/pr300918r
Liu, X., Happel, C., & Ziegelbauer, J. M. (2017). Kaposi's sarcoma-associated herpesvirus microRNAs target GADD45B to protect infected cells
from cell cycle arrest and apoptosis. Journal of Virology, 91, e02045-16. https://doi.org/10.1128/JVI.02045-16
Lötvall, J., Hill, A. F., Hochberg, F., Buzás, E. I., Di Vizio, D., Gardiner, C.,… Théry, C. (2014). Minimal experimental requirements for definition
of extracellular vesicles and their functions: A position statement from the International Society for Extracellular Vesicles. Journal of Extracellu-
lar Vesicles, 3, 26913. https://doi.org/10.3402/JEV.V3.26913
Lu, Y., Qin, Z., Wang, J., Zheng, X., Lu, J., Zhang, X.,… Ma, J. (2017). Epstein–Barr virus miR-BART6-3p inhibits the RIG-I pathway. Journal of
Innate Immunity, 9, 574–586. https://doi.org/10.1159/000479749
Maemura, T., Fukuyama, S., Sugita, Y., Lopes, T. J. S., Nakao, T., Noda, T., & Kawaoka, Y. (2018). Lung-derived exosomal miR-483-3p regulates the
innate immune response to influenza virus infection. The Journal of Infectious Diseases, 217, 1372–1382. https://doi.org/10.1093/infdis/jiy035
Mahajan, V. S., Drake, A., & Chen, J. (2009). Virus-specific host miRNAs: Antiviral defenses or promoters of persistent infection? Trends in Immu-
nology, 30, 1–7. https://doi.org/10.1016/j.it.2008.08.009
Mao, L., Wu, J., Shen, L., Yang, J., Chen, J., & Xu, H. (2016). Enterovirus 71 transmission by exosomes establishes a productive infection in human
neuroblastoma cells. Virus Genes, 52, 189–194. https://doi.org/10.1007/s11262-016-1292-3
Marcinowski, L., Tanguy, M., Krmpotic, A., Rädle, B., Lisnic, V. J., Tuddenham, L., … Dölken, L. (2012). Degradation of cellular miR-27 by a
novel, highly abundant viral transcript is important for efficient virus replication in vivo. PLoS Pathogens, 8, e1002510. https://doi.org/10.1371/
journal.ppat.1002510
Masciopinto, F., Giovani, C., Campagnoli, S., Galli-Stampino, L., Colombatto, P., Brunetto, M.,… Abrignani, S. (2004). Association of hepatitis C
virus envelope proteins with exosomes. European Journal of Immunology, 34, 2834–2842. https://doi.org/10.1002/eji.200424887
Mateescu, B., Kowal, E. J. K., van Balkom, B. W. M., Bartel, S., Bhattacharyya, S. N., Buzás, E. I., … Nolte-'t Hoen, E. N. M. (2017). Obstacles
and opportunities in the functional analysis of extracellular vesicle RNA—an ISEV position paper. Journal of Extracellular Vesicles, 6,
1286095. https://doi.org/10.1080/20013078.2017.1286095
McCaskill, J., Praihirunkit, P., Sharp, P. M., & Buck, A. H. (2015). RNA-mediated degradation of microRNAs: A widespread viral strategy? RNA
Biology, 12, 579–585. https://doi.org/10.1080/15476286.2015.1034912
McKenzie, A. J., Hoshino, D., Hong, N. H., Cha, D. J., Franklin, J. L., Coffey, R. J., … Weaver, A. M. (2016). KRAS-MEK signaling controls
Ago2 sorting into exosomes. Cell Reports, 15(5), 978–987. https://doi.org/10.1016/j.celrep.2016.03.085
Meerloo, T., Sheikh, M. A., Bloem, A. C., de Ronde, A., Schutten, M., van Els, C. A.,… Schuurman, H. J. (1993). Host cell membrane proteins on
human immunodeficiency virus type 1 after in vitro infection of H9 cells and blood mononuclear cells. An immuno-electron microscopic study.
Journal of General Virology, 74(Pt. 1), 129–135. https://doi.org/10.1099/0022-1317-74-1-129
Mendell, J. T., & Olson, E. N. (2012). MicroRNAs in stress signaling and human disease. Cell, 148(6), 1172–1187. https://doi.org/10.1016/j.cell.
2012.02.005
Mercer, J., Schelhaas, M., & Helenius, A. (2010). Virus entry by endocytosis. Annual Review of Biochemistry, 79, 803–833. https://doi.org/10.1146/
annurev-biochem-060208-104626
Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L.,… Tewari, M. (2008). Circulating microRNAs
as stable blood-based markers for cancer detection. Proceedings of the National Academy of Sciences, 105, 10513–10518. https://doi.org/10.
1073/pnas.0804549105
Montecalvo, A., Larregina, A. T., Shufesky, W. J., Stolz, D. B., Sullivan, M. L. G., Karlsson, J. M.,…Morelli, A. E. (2012). Mechanism of transfer
of functional microRNAs between mouse dendritic cells via exosomes. Blood, 119, 756–766. https://doi.org/10.1182/blood-2011-02-338004
Morelli, A. E., Larregina, A. T., Shufesky, W. J., Sullivan, M. L. G., Stolz, D. B., Papworth, G. D., … Thomson, A. W. (2004). Endocytosis, intra-
cellular sorting, and processing of exosomes by dendritic cells. Blood, 104, 3257–3266. https://doi.org/10.1182/blood-2004-03-0824
Mori, Y., Koike, M., Moriishi, E., Kawabata, A., Tang, H., Oyaizu, H., … Yamanishi, K. (2008). Human herpesvirus-6 induces MVB formation,
and virus egress occurs by an exosomal release pathway. Traffic, 9, 1728–1742. https://doi.org/10.1111/j.1600-0854.2008.00796.x
Mukherjee, S., Akbar, I., Kumari, B., Vrati, S., Basu, A., & Banerjee, A. (2018). Japanese encephalitis virus-induced let-7a/b interacted with the
NOTCH-TLR7 pathway in microglia and facilitated neuronal death via caspase activation. Journal of Neurochemistry. Epub ahead of print.
https://doi.org/10.1111/jnc.14645
Mulcahy, L. A., Pink, R. C., & Carter, D. R. F. (2014). Routes and mechanisms of extracellular vesicle uptake. Journal of Extracellular Vesicles, 3,
24641. https://doi.org/10.3402/jev.v3.24641
Munshi, A., Mohan, V., & Ahuja, Y. (2016). Non-coding RNAs: A dynamic and complex network of gene regulation. Journal of Pharmaco-
genomics & Pharmacoproteomics, 7, 2153–0645. https://doi.org/10.4172/2153-0645.1000156
Nabet, B. Y., Qiu, Y., Shabason, J. E., Wu, T. J., Yoon, T., Kim, B. C.,…Minn, A. J. (2017). Exosome RNA unshielding couples stromal activation
to pattern recognition receptor signaling in cancer. Cell, 170, 352–366.e313. https://doi.org/10.1016/J.CELL.2017.06.031
Nakase, I., Kobayashi, N. B., Takatani-Nakase, T., & Yoshida, T. (2015). Active macropinocytosis induction by stimulation of epidermal growth
factor receptor and oncogenic Ras expression potentiates cellular uptake efficacy of exosomes. Scientific Reports, 5, 10300. https://doi.org/10.
1038/srep10300
20 of 23 RESSEL ET AL.
Nanbo, A., Kawanishi, E., Yoshida, R., & Yoshiyama, H. (2013). Exosomes derived from Epstein–Barr virus-infected cells are internalized via
caveola-dependent endocytosis and promote phenotypic modulation in target cells. Journal of Virology, 87, 10334–10347. https://doi.org/10.
1128/JVI.01310-13
Narayanan, A., Iordanskiy, S., Das, R., Van Duyne, R., Santos, S., Jaworski, E., … Kashanchi, F. (2013). Exosomes derived from HIV-1-infected
cells contain trans-activation response element RNA. Journal of Biological Chemistry, 288, 20014–20033. https://doi.org/10.1074/jbc.M112.
438895
Narayanan, A., Kehn-Hall, K., Bailey, C., & Kashanchi, F. (2011). Analysis of the roles of HIV-derived microRNAs. Expert Opinion on Biological
Therapy, 11, 17–29. https://doi.org/10.1517/14712598.2011.540564
Nolte-'t Hoen, E. N. M., Buermans, H. P. J., Waasdorp, M., Stoorvogel, W., Wauben, M. H. M., & 't Hoen, P. A. C. (2012). Deep sequencing of
RNA from immune cell-derived vesicles uncovers the selective incorporation of small non-coding RNA biotypes with potential regulatory func-
tions. Nucleic Acids Research, 40, 9272–9285. https://doi.org/10.1093/nar/gks658
Novellino, L., Rossi, R. L., Bonino, F., Cavallone, D., Abrignani, S., Pagani, M., & Brunetto, M. R. (2012). Circulating hepatitis B surface antigen
particles carry hepatocellular microRNAs. PLoS One, 7, e31952. https://doi.org/10.1371/journal.pone.0031952
Obbard, D. J., Gordon, K. H. J., Buck, A. H., & Jiggins, F. M. (2009). The evolution of RNAi as a defence against viruses and transposable ele-
ments. Philosophical Transactions of the Royal Society of London Series B: Biological Sciences, 364, 99–115. https://doi.org/10.1098/rstb.2008.
0168
Orentas, R. J., & Hildreth, J. E. (1993). Association of host cell surface adhesion receptors and other membrane proteins with HIV and SIV. AIDS
Research and Human Retroviruses, 9(11), 1157–1165. https://doi.org/10.1089/aid.1993.9.1157
Ouellet, D. L., Plante, I., Landry, P., Barat, C., Janelle, M.-E., Flamand, L., … Provost, P. (2008). Identification of functional microRNAs released
through asymmetrical processing of HIV-1 TAR element. Nucleic Acids Research, 36, 2353–2365. https://doi.org/10.1093/nar/gkn076
Ouyang, Y., Bayer, A., Chu, T., Tyurin, V. A., Kagan, V. E., Morelli, A. E., … Sadovsky, Y. (2016). Isolation of human trophoblastic extracellular
vesicles and characterization of their cargo and antiviral activity. Placenta, 47, 86–95. https://doi.org/10.1016/J.PLACENTA.2016.09.008
Pare, J. M., & Sullivan, C. S. (2014). Distinct antiviral responses in pluripotent versus differentiated cells. PLoS Pathogens, 10(2), e1003865.
https://doi.org/10.1371/journal.ppat.1003865
Parolini, I., Federici, C., Raggi, C., Lugini, L., Palleschi, S., De Milito, A., … Fais, S. (2009). Microenvironmental pH is a key factor for exosome
traffic in tumor cells. Journal of Biological Chemistry, 284, 34211–34222. https://doi.org/10.1074/jbc.M109.041152
Pegtel, D. M., Cosmopoulos, K., Thorley-Lawson, D. A., van Eijndhoven, M. A. J., Hopmans, E. S., Lindenberg, J. L., … Middeldorp, J. M.
(2010). Functional delivery of viral miRNAs via exosomes. Proceedings of the National Academy of Sciences of the United States of America,
107, 6328–6333. https://doi.org/10.1073/pnas.0914843107
Pérez-Boza, J., Lion, M., & Struman, I. (2018). Exploring the RNA landscape of endothelial exosomes. RNA, 24, 423–435. https://doi.org/10.1261/
rna.064352.117
Pfeffer, S., Zavolan, M., Grässer, F. A., Chien, M., Russo, J. J., Ju, J., … Tuschl, T. (2004). Identification of virus-encoded microRNAs. Science,
304(5671), 734–736. https://doi.org/10.1126/science.1096781
Raab-Traub, N., & Dittmer, D. P. (2017). Viral effects on the content and function of extracellular vesicles. Nature Reviews. Microbiology, 15,
559–572. https://doi.org/10.1038/nrmicro.2017.60
Ramakrishnaiah, V., Thumann, C., Fofana, I., Habersetzer, F., Pan, Q., de Ruiter, P. E., … van der Laan, L. J. W. (2013). Exosome-mediated trans-
mission of hepatitis C virus between human hepatoma Huh7.5 cells. Proceedings of the National Academy of Sciences of the United States of
America, 110, 13109–13113. https://doi.org/10.1073/pnas.1221899
Ridder, K., Keller, S., Dams, M., Rupp, A.-K., Schlaudraff, J., Del Turco, D., … Momma, S. (2014). Extracellular vesicle-mediated transfer of
genetic information between the hematopoietic system and the brain in response to inflammation. PLoS Biology, 12, e1001874. https://doi.org/
10.1371/journal.pbio.1001874
Ridder, K., Sevko, A., Heide, J., Dams, M., Rupp, A.-K., Macas, J., … Momma, S. (2015). Extracellular vesicle-mediated transfer of functional
RNA in the tumor microenvironment. OncoImmunology, 4, e1008371. https://doi.org/10.1080/2162402X.2015.1008371
Rudt, S., & Müller, R. H. (1993). In vitro phagocytosis assay of nano- and microparticles by chemiluminescence. III. Uptake of differently sized
surface-modified particles, and its correlation to particle properties and in vivo distribution. European Journal of Pharmaceutical Sciences, 1,
31–39. https://doi.org/10.1016/0928-0987(93)90015-3
Ruggero, K., Guffanti, A., Corradin, A., Sharma, V. K., De Bellis, G., Corti, G.,… D'Agostino, D. M. (2014). Small noncoding RNAs in cells trans-
formed by human T-cell leukemia virus type 1: A role for a tRNA fragment as a primer for reverse transcriptase. Journal of Virology, 88,
3612–3622. https://doi.org/10.1128/JVI.02823-13
Sampey, G. C., Saifuddin, M., Schwab, A., Barclay, R., Punya, S., Chung, M.-C., … Kashanchi, F. (2016). Exosomes from HIV-1-infected cells
stimulate production of pro-inflammatory cytokines through trans-activating response (TAR) RNA. Journal of Biological Chemistry, 291,
1251–1266. https://doi.org/10.1074/jbc.M115.662171
Santangelo, L., Giurato, G., Cicchini, C., Montaldo, C., Mancone, C., Tarallo, R., … Tripodi, M. (2016). The RNA-binding protein SYNCRIP is a
component of the hepatocyte exosomal machinery controlling microRNA sorting. Cell Reports, 17(3), 799–808. https://doi.org/10.1016/j.celrep.
2016.09.031
Sarnow, P., & Sagan, S. M. (2016). Unraveling the mysterious interactions between hepatitis C virus RNA and liver-specific microRNA-122.
Annual Review of Virology, 3, 309–332. https://doi.org/10.1146/annurev-virology-110615-042409
RESSEL ET AL. 21 of 23
Scheller, N., Herold, S., Kellner, R., Bertrams, W., Jung, A. L., Janga, H.,… Schmeck, B. (2018). Proviral microRNAs detected in extracellular ves-
icles from bronchoalveolar lavage fluid of patients with influenza virus-induced acute respiratory distress syndrome. Journal of Infectious Dis-
eases, 219, 540–543. https://doi.org/10.1093/infdis/jiy554
Schmieder, R., Lim, Y. W., & Edwards, R. (2012). Identification and removal of ribosomal RNA sequences from metatranscriptomes. Bioinformat-
ics, 28, 433–435. https://doi.org/10.1093/bioinformatics/btr669
Schopman, N. C. T., Willemsen, M., Liu, Y. P., Bradley, T., van Kampen, A., Baas, F., … Haasnoot, J. (2012). Deep sequencing of virus-infected
cells reveals HIV-encoded small RNAs. Nucleic Acids Research, 40, 414–427. https://doi.org/10.1093/nar/gkr719
Schorey, J. S., Cheng, Y., Singh, P. P., & Smith, V. L. (2015). Exosomes and other extracellular vesicles in host–pathogen interactions. EMBO
Reports, 16, 24–43. https://doi.org/10.15252/embr.201439363
Selitsky, S. R., Baran-Gale, J., Honda, M., Yamane, D., Masaki, T., Fannin, E. E., … Sethupathy, P. (2015). Small tRNA-derived RNAs are
increased and more abundant than microRNAs in chronic hepatitis B and C. Scientific Reports, 5, 7675. https://doi.org/10.1038/srep07675
Seo, G. J., Kincaid, R. P., Phanaksri, T., Burke, J. M., Pare, J. M., Cox, J. E.,… Sullivan, C. S. (2013). Reciprocal inhibition between intracellular ant-
iviral signaling and the RNAi machinery in mammalian cells. Cell Host & Microbe, 14, 435–445. https://doi.org/10.1016/J.CHOM.2013.09.002
Shelke, G. V., Lässer, C., Gho, Y. S., & Lötvall, J. (2014). Importance of exosome depletion protocols to eliminate functional and RNA-containing
extracellular vesicles from fetal bovine serum. Journal of Extracellular Vesicles, 3, 24783. https://doi.org/10.3402/jev.v3.24783
Shimakami, T., Yamane, D., Jangra, R. K., Kempf, B. J., Spaniel, C., Barton, D. J., & Lemon, S. M. (2012). Stabilization of hepatitis C virus RNA
by an Ago2-miR-122 complex. Proceedings of the National Academy of Sciences of the United States of America, 109, 941–946. https://doi.org/
10.1073/pnas.1112263109
Skog, J., Würdinger, T., van Rijn, S., Meijer, D. H., Gainche, L., Curry, W. T., … Breakefield, X. O. (2008). Glioblastoma microvesicles transport
RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nature Cell Biology, 10, 1470–1476. https://doi.org/10.1038/
ncb1800
Sohel, M. H. (2016). Extracellular/circulating microRNAs: Release mechanisms, functions and challenges. Achievements in the Life Sciences, 10,
175–186. https://doi.org/10.1016/J.ALS.2016.11.007
Stalder, L., Heusermann, W., Sokol, L., Trojer, D., Wirz, J., Hean, J.,… Meisner-Kober, N. C. (2013). The rough endoplasmatic reticulum is a cen-
tral nucleation site of siRNA-mediated RNA silencing. EMBO Journal, 32(8), 1115–1127. https://doi.org/10.1038/emboj.2013.52
Stroun, M., Anker, P., Beljanski, M., Henri, J., Lederrey, C., Ojha, M., & Maurice, P. A. (1978). Presence of RNA in the nucleoprotein complex
spontaneously released by human lymphocytes and frog auricles in culture. Cancer Research, 38, 3546–3554.
Sullivan, C. S., Grundhoff, A. T., Tevethia, S., Pipas, J. M., & Ganem, D. (2005). SV40-encoded microRNAs regulate viral gene expression and
reduce susceptibility to cytotoxic T cells. Nature, 435, 682–686. https://doi.org/10.1038/nature03576
Svensson, K. J., Christianson, H. C., Wittrup, A., Bourseau-Guilmain, E., Lindqvist, E., Svensson, L. M., … Belting, M. (2013). Exosome uptake
depends on ERK1/2-heat shock protein 27 signaling and lipid raft-mediated endocytosis negatively regulated by caveolin-1. Journal of Biologi-
cal Chemistry, 288, 17713–17724. https://doi.org/10.1074/jbc.M112.445403
tenOever, B. R. (2017). Questioning antiviral RNAi in mammals. Nature Microbiology, 2, 17052. https://doi.org/10.1038/nmicrobiol.2017.52
Théry, C., Amigorena, S., Raposo, G., & Clayton, A. (2006). Isolation and characterization of exosomes from cell culture supernatants and biologi-
cal fluids. Current Protocols in Cell Biology, 30, 3.22.21–3.22.29. https://doi.org/10.1002/0471143030.cb0322s30
Théry, C., Witwer, K. W., Aikawa, E., Alcaraz, M. J., Anderson, J. D., Andriantsitohaina, R., … Zuba-Surma, E. K. (2018). Minimal information
for studies of extracellular vesicles 2018 (MISEV2018): A position statement of the International Society for Extracellular Vesicles and update
of the MISEV2014 guidelines. Journal of Extracellular Vesicles, 7(1), 1535750. https://doi.org/10.1080/20013078.2018.1535750
Thompson, A. I., Conroy, K. P., & Henderson, N. C. (2015). Hepatic stellate cells: Central modulators of hepatic carcinogenesis. BMC Gastroenter-
ology, 15, 63. https://doi.org/10.1186/s12876-015-0291-5
Tian, T., Zhu, Y.-L., Zhou, Y.-Y., Liang, G.-F., Wang, Y.-Y., Hu, F.-H., & Xiao, Z.-D. (2014). Exosome uptake through clathrin-mediated endocy-
tosis and macropinocytosis and mediating miR-21 delivery. Journal of Biological Chemistry, 289, 22258–22267. https://doi.org/10.1074/jbc.
M114.588046
Tosar, J. P., Cayota, A., Eitan, E., Halushka, M. K., Witwer, K. W., & Schiffelers, R. (2017). Ribonucleic artefacts: Are some extracellular RNA discov-
eries driven by cell culture medium components? Journal of Extracellular Vesicles, 6, 1272832. https://doi.org/10.1080/20013078.2016.1272832
Tosar, J. P., Gámbaro, F., Darré, L., Pantano, S., Westhof, E., & Cayota, A. (2018). Dimerization confers increased stability to nucleases in 50 halves
from glycine and glutamic acid tRNAs. Nucleic Acids Research, 46, 9081–9093. https://doi.org/10.1093/nar/gky495
Tosar, J. P., Gambaro, F., Sanguinetti, J., Bonilla, B., Witwer, K. W., & Cayota, A. (2015). Assessment of small RNA sorting into different extracellular
fractions revealed by high-throughput sequencing of breast cell lines. Nucleic Acids Research, 43, 5601–5616. https://doi.org/10.1093/nar/gkv432
Trobaugh, D. W., Gardner, C. L., Sun, C., Haddow, A. D., Wang, E., Chapnik, E., … Klimstra, W. B. (2014). RNA viruses can hijack vertebrate
microRNAs to suppress innate immunity. Nature, 506, 245–248. https://doi.org/10.1038/nature12869
Trobaugh, D. W., & Klimstra, W. B. (2017). MicroRNA regulation of RNA virus replication and pathogenesis. Trends in Molecular Medicine, 23,
80–93. https://doi.org/10.1016/J.MOLMED.2016.11.003
Tycowski, K. T., Guo, Y. E., Lee, N., Moss, W. N., Vallery, T. K., Xie, M., & Steitz, J. A. (2015). Viral noncoding RNAs: More surprises. Genes &
Development, 29, 567–584. https://doi.org/10.1101/gad.259077.115
Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007). Exosome-mediated transfer of mRNAs and microRNAs is a
novel mechanism of genetic exchange between cells. Nature Cell Biology, 9, 654–659. https://doi.org/10.1038/ncb1596
van der Grein, S. G., Defourny, K. A. Y., Slot, E. F. J., & Nolte-'t Hoen, E. N. M. (2018). Intricate relationships between naked viruses and extracellular
vesicles in the crosstalk between pathogen and host. Seminars in Immunopathology, 40, 491–504. https://doi.org/10.1007/s00281-018-0678-9
22 of 23 RESSEL ET AL.
van der Grein, S. G., & Nolte-'t Hoen, E. N. (2014). "Small talk" in the innate immune system via RNA-containing extracellular vesicles. Frontiers
in Immunology, 5, 542. https://doi.org/10.3389/fimmu.2014.00542
van Dongen, H. M., Masoumi, N., Witwer, K. W., & Pegtel, D. M. (2016). Extracellular vesicles exploit viral entry routes for cargo delivery. Micro-
biology and Molecular Biology Reviews, 80, 369–386. https://doi.org/10.1128/MMBR.00063-15
Villarroya-Beltri, C., Gutiérrez-Vázquez, C., Sánchez-Cabo, F., Pérez-Hernández, D., Vázquez, J., Martin-Cofreces, N., … Sánchez-Madrid, F.
(2013). Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nature Communications, 4,
2980. https://doi.org/10.1038/ncomms3980
Wang, Q., Lee, I., Ren, J., Ajay, S. S., Lee, Y. S., & Bao, X. (2013). Identification and functional characterization of tRNA-derived RNA fragments
(tRFs) in respiratory syncytial virus infection. Molecular Therapy, 21, 368–379. https://doi.org/10.1038/mt.2012.237
Wang, W., Li, J., Zhang, X., Wen, Y., Wang, X.-Y., & Yuan, Z. (2016). A pilot study of microRNAs expression profile in serum and HBsAg parti-
cles. Medicine, 95, e2511. https://doi.org/10.1097/MD.0000000000002511
Wang, Y., Li, H., Sun, Q., & Yao, Y. (2016). Characterization of small RNAs derived from tRNAs, rRNAs and snoRNAs and their response to heat
stress in wheat seedlings. PLoS One, 11, e0150933. https://doi.org/10.1371/journal.pone.0150933
Watanabe, T., Sorensen, E. M., Naito, A., Schott, M., Kim, S., & Ahlquist, P. (2007). Involvement of host cellular multivesicular body functions in
hepatitis B virus budding. Proceedings of the National Academy of Sciences of the United States of America, 104(24), 10205–10210. https://doi.
org/10.1073/pnas.0704000104
Wei, Z., Batagov, A. O., Carter, D. R. F., & Krichevsky, A. M. (2016). Fetal bovine serum RNA interferes with the cell culture derived extracellular
RNA. Scientific Reports, 6, 31175. https://doi.org/10.1038/srep31175
Wei, Z., Batagov, A. O., Schinelli, S., Wang, J., Wang, Y., El Fatimy, R., … Krichevsky, A. M. (2017). Coding and noncoding landscape of extra-
cellular RNA released by human glioma stem cells. Nature Communications, 8, 1145. https://doi.org/10.1038/s41467-017-01196-x
Witteveldt, J., Ivens, A., & Macias, S. (2018). Inhibition of microprocessor function during the activation of the type I interferon response. Cell
Reports, 23, 3275–3285. https://doi.org/10.1016/j.celrep.2018.05.049
Witwer, K. W., Sisk, J. M., Gama, L., & Clements, J. E. (2010). MicroRNA regulation of IFN-β protein expression: Rapid and sensitive modulation
of the innate immune response. Journal of Immunology, 184, 2369–2376. https://doi.org/10.4049/JIMMUNOL.0902712
Wu, M., Ouyang, Y., Wang, Z., Zhang, R., Huang, P.-H., Chen, C., … Huang, T. J. (2017). Isolation of exosomes from whole blood by integrating
acoustics and microfluidics. Proceedings of the National Academy of Sciences of the United States of America, 114, 10584–10589. https://doi.
org/10.1073/pnas.1709210
Wu, S., He, L., Li, Y., Wang, T., Feng, L., Jiang, L.,… Huang, X. (2013). miR-146a facilitates replication of dengue virus by dampening interferon
induction by targeting TRAF6. Journal of Infection, 67, 329–341. https://doi.org/10.1016/J.JINF.2013.05.003
Xie, M., & Steitz, J. A. (2014). Versatile microRNA biogenesis in animals and their viruses. RNA Biology, 11, 673–681. https://doi.org/10.4161/
RNA.28985
Yáñez-Mó, M., R-M Siljander, P., Andreu, Z., Bedina Zavec, A., Borràs, F. E., Buzas, E. I.,… De Wever, O. (2015). Biological properties of extra-
cellular vesicles and their physiological functions. Journal of Extracellular Vesicles, 4, 27066. https://doi.org/10.3402/jev.v4.27066
Yeung, M. L., Bennasser, Y., Watashi, K., Le, S.-Y., Houzet, L., & Jeang, K.-T. (2009). Pyrosequencing of small non-coding RNAs in HIV-1
infected cells: Evidence for the processing of a viral-cellular double-stranded RNA hybrid. Nucleic Acids Research, 37, 6575–6586. https://doi.
org/10.1093/nar/gkp707
Yin, C., Evason, K. J., Asahina, K., & Stainier, D. Y. (2013). Hepatic stellate cells in liver development, regeneration, and cancer. Journal of Clini-
cal Investigation, 123(5), 1902–1910. https://doi.org/10.1172/JCI66369
Yogev, O., Henderson, S., Hayes, M. J., Marelli, S. S., Ofir-Birin, Y., Regev-Rudzki, N.,… Enver, T. (2017). Herpesviruses shape tumour microen-
vironment through exosomal transfer of viral microRNAs. PLoS Pathogens, 13, e1006524. https://doi.org/10.1371/journal.ppat.1006524
Yoshida, R., Takaesu, G., Yoshida, H., Okamoto, F., Yoshioka, T., Choi, Y., … Kobayashi, T. (2008). TRAF6 and MEKK1 play a pivotal role in
the RIG-I-like helicase antiviral pathway. Journal of Biological Chemistry, 283, 36211–36220. https://doi.org/10.1074/jbc.M806576200
Zhang, Y., Zhang, Y., Shi, J., Zhang, H., Cao, Z., Gao, X.,… Duan, E. (2014). Identification and characterization of an ancient class of small RNAs
enriched in serum associating with active infection. Journal of Molecular Cell Biology, 6, 172–174. https://doi.org/10.1093/jmcb/mjt052
Zhou, D., Xue, J., He, S., Du, X., Zhou, J., Li, C., … Cheng, Z. (2018). Reticuloendotheliosis virus and avian leukosis virus subgroup J synergisti-
cally increase the accumulation of exosomal miRNAs. Retrovirology, 15, 45. https://doi.org/10.1186/s12977-018-0427-0
Zhou, Y., Wang, X., Sun, L., Zhou, L., Ma, T.-C., Song, L.,… Ho, W.-Z. (2016). Toll-like receptor 3-activated macrophages confer anti-HCV activ-
ity to hepatocytes through exosomes. FASEB Journal, 30, 4132–4140. https://doi.org/10.1096/fj.201600696R
Zomer, A., Maynard, C., Verweij, F. J., Kamermans, A., Schäfer, R., Beerling, E., … van Rheenen, J. (2015). Vivo imaging reveals extracellular
vesicle-mediated phenocopying of metastatic behavior. Cell, 161, 1046–1057. https://doi.org/10.1016/J.CELL.2015.04.042
Zomer, A., Steenbeek, S. C., Maynard, C., & van Rheenen, J. (2016). Studying extracellular vesicle transfer by a Cre-loxP method. Nature Proto-
cols, 11, 87–101. https://doi.org/10.1038/nprot.2015.138
How to cite this article: Ressel S, Rosca A, Gordon K, Buck AH. Extracellular RNA in viral–host interactions:
Thinking outside the cell. WIREs RNA. 2019;e1535. https://doi.org/10.1002/wrna.1535
RESSEL ET AL. 23 of 23
